10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 ___________________________________________________________

FORM 10-Q

___________________________________________________________

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 24, 2017

or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-12933

___________________________________________________________

LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________________

Delaware	94-2634797
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

4650 Cushing Parkway Fremont, California	94538
(Address of principal executive offices)	(Zip Code)

(510) 572-0200

(Registrant’s telephone number, including area code)

__________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨  (Do not check if a smaller reporting company)	Smaller reporting company	¨
		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of October 19, 2017, the Registrant had 161,946,248 shares of Common Stock outstanding.

LAM RESEARCH CORPORATION

TABLE OF CONTENTS

		Page No.
	PART I. Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Statements of Operations for the three months ended September 24, 2017, and September 25, 2016	3
	Condensed Consolidated Statements of Comprehensive Income for the three months ended September 24, 2017, and September 25, 2016	4
	Condensed Consolidated Balance Sheets as of September 24, 2017, and June 25, 2017	5
	Condensed Consolidated Statements of Cash Flows for the three months ended September 24, 2017, and September 25, 2016	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	33
Item 4.	Controls and Procedures	34
	PART II. Other Information
Item 1.	Legal Proceedings	35
Item 1A.	Risk Factors	35
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
Item 3.	Defaults Upon Senior Securities	46
Item 4.	Mine Safety Disclosures	46
Item 5.	Other Information	46
Item 6.	Exhibits	46
Signatures		47
Exhibit Index		48

PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

	Three Months Ended
	September 24, 2017			September 25, 2016
Revenue	$	2,478,140		$	1,632,419
Cost of goods sold	1,328,797			916,222
Gross margin	1,149,343			716,197
Research and development	275,078			235,240
Selling, general, and administrative	181,043			165,010
Total operating expenses	456,121			400,250
Operating income	693,222			315,947
Other expense, net	(5,502		)	(23,154		)
Income before income taxes	687,720			292,793
Income tax expense	(97,030		)	(28,958		)
Net income	$	590,690		$	263,835
Net income per share:
Basic	$	3.64		$	1.64
Diluted	$	3.21		$	1.47
Number of shares used in per share calculations:
Basic	162,141			160,607
Diluted	183,880			180,017
Cash dividend declared per common share	$	0.45		$	0.30

3

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

(unaudited)

	Three Months Ended
	September 24, 2017			September 25, 2016
Net income	$	590,690		$	263,835
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	7,869			4,501
Cash flow hedges:
Net unrealized gains (losses) during the period	3,062			(2,421		)
Net losses reclassified into earnings	2,188			11,950
	5,250			9,529
Available-for-sale investments:
Net unrealized losses during the period	(1,727		)	(2,723		)
Net (gains) losses reclassified into earnings	(123		)	903
	(1,850		)	(1,820		)
Defined benefit plans, net change in unrealized component	(2,356		)	123
Other comprehensive income, net of tax	8,913			12,333
Comprehensive income	$	599,603		$	276,168

See Notes to Condensed Consolidated Financial Statements

4

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

	September 24, 2017			June 25, 2017
	(unaudited)			(1)
ASSETS
Cash and cash equivalents	$	2,406,462		$	2,377,534
Investments	3,775,925			3,663,628
Accounts receivable, less allowance for doubtful accounts of $5,271 as of September 24, 2017, and $5,103 as of June 25, 2017	1,530,762			1,673,398
Inventories	1,328,297			1,232,916
Prepaid expenses and other current assets	187,334			195,022
Total current assets	9,228,780			9,142,498
Property and equipment, net	745,600			685,595
Restricted cash and investments	256,045			256,205
Goodwill	1,484,030			1,385,673
Intangible assets, net	420,359			410,995
Other assets	263,812			241,799
Total assets	$	12,398,626		$	12,122,765
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	471,805		$	464,643
Accrued expenses and other current liabilities	1,078,998			969,361
Deferred profit	597,921			607,672
Current portion of convertible notes and capital leases	639,907			908,439
Total current liabilities	2,788,631			2,950,115
Senior notes, convertible notes, and capital leases, less current portion	1,793,477			1,784,974
Income taxes payable	129,611			120,178
Other long-term liabilities	278,733			280,186
Total liabilities	4,990,452			5,135,453
Commitments and contingencies
Temporary equity, convertible notes	136,996			169,861
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding	—			—
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 162,144 shares at September 24, 2017, and 161,723 shares at June 25, 2017	162			162
Additional paid-in capital	5,891,549			5,845,485
Treasury stock, at cost; 107,360 shares at September 24, 2017, and 105,569 shares at June 25, 2017	(5,375,920		)	(5,216,187		)
Accumulated other comprehensive loss	(52,787		)	(61,700		)
Retained earnings	6,808,174			6,249,691
Total stockholders’ equity	7,271,178			6,817,451
Total liabilities and stockholders’ equity	$	12,398,626		$	12,122,765

(1) Derived from audited financial statements

See Notes to Condensed Consolidated Financial Statements

5

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Three Months Ended
	September 24, 2017			September 25, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	590,690		$	263,835
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	79,142			74,562
Deferred income taxes	43,204			7,633
Equity-based compensation expense	41,783			38,595
Amortization of note discounts and issuance costs	4,588			6,830
Other, net	6,569			16,807
Changes in operating assets and liabilities	92,330			64,962
Net cash provided by operating activities	858,306			473,224
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(60,064		)	(41,979		)
Business acquisition, net of cash acquired	(115,613		)	—
Purchases of available-for-sale securities	(1,425,407		)	(38,149		)
Sales and maturities of available-for-sale securities	1,307,633			469,899
Transfers of restricted cash and investments	160			(5,219		)
Other, net	(10,600		)	(7,800		)
Net cash (used for) provided by investing activities	(303,891		)	376,752
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs	(301,727		)	(371		)
Treasury stock purchases	(155,385		)	(1,854		)
Dividends paid	(72,738		)	(48,052		)
Reissuance of treasury stock related to employee stock purchase plan	—			19,320
Proceeds from issuance of common stock	1,042			1,459
Other, net	4			(10		)
Net cash used for financing activities	(528,804		)	(29,508		)
Effect of exchange rate changes on cash and cash equivalents	3,317			1,911
Net increase in cash and cash equivalents	28,928			822,379
Cash and cash equivalents at beginning of period	2,377,534			5,039,322
Cash and cash equivalents at end of period	$	2,406,462		$	5,861,701
Schedule of non-cash transactions:
Accrued payables for stock repurchases	4,350			—
Accrued payables for capital expenditures	34,531			11,631
Dividends payable	73,127			48,397
Transfers of inventory to property and equipment, net	11,852			13,419

See Notes to Condensed Consolidated Financial Statements

6

LAM RESEARCH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 24, 2017

(Unaudited)

NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 25, 2017, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 25, 2017 (the “2017 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 24, 2018 and includes 52 weeks. The quarters ended September 24, 2017 (the “September 2017 quarter”) and September 25, 2016 (the “September 2016 quarter”) included 13 weeks.

NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted

In November 2015, the Financial Accounting Standards Board (“FASB”) issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The Company adopted this standard prospectively in the first quarter of fiscal year 2018. The implementation resulted in a net reduction of prepaid expense and other current assets of $49.7 million, accrued expense and other current liabilities of $5.3 million, and other long-term liabilities of $39.4 million; and an increase in other assets of $5.0 million in the Company’s Condensed Consolidated Balance Sheet, and had no impact on cash provided by or used in operations for any period presented.

In March 2016, the FASB released ASU 2016-9, “Compensation – Stock Compensation.” Key changes in the amendment include:

• entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating additional paid in capital (“APIC”) pools;

• entities will no longer be required to delay recognition of excess tax benefits until they are realized;

• entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows;

• entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur;

• entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability; and

• the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows.

The Company adopted this standard in the first quarter of fiscal year 2018. As a result of the adoption, the Company recorded a $40.9 million cumulative-effect adjustment to retained earnings for the recognition of previously unrecognized excess tax benefits for all years prior to the adoption. As required by the standard update, the amendment was applied prospectively to recognize excess tax benefits or deficiencies in the income statement in the period of occurrence. Additionally, the Company has elected to apply the change in cash flow classification on a prospective basis. The Company has elected to continue to estimate the number of forfeitures expected to occur to determine the amount of compensation cost to be recognized each

7

period. The Company has elected to adopt the effects of the standard update with regard to the income tax withholdings obligations on a prospective basis, such withholdings in the period ended September 24, 2017 were not material.

Updates Not Yet Effective

In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers,” to supersede nearly all existing revenue recognition guidance under GAAP. The FASB issued subsequent amendments to the initial guidance in August 2015, March 2016, April 2016, May 2016 and December 2016 within ASU 2015-14, ASU 2016-08, ASU 2016-10, ASU 2016-12 and ASU 2016-20, respectively. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each separate performance obligation.

The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (1) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (2) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method. The Company is continuing its evaluation of the impact that the new standard will have on its Condensed Consolidated Financial Statements and disclosures, business processes, systems, and controls. While the Company’s evaluation of the impact of the standard on its financial statements with respect to its spare parts and service revenue has not been completed, the Company believes that the timing of revenue recognition for certain of its systems will generally be earlier than under existing revenue recognition guidance. The Company continues to evaluate the impact to its revenues related to its pending adoption of these standards and its preliminary assessments are subject to change.

In January 2016, the FASB released ASU 2016-1, “Financial Instruments – Overall – Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity’s other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact on its Condensed Consolidated Financial Statements.

In January 2016, the FASB released ASU 2016-2, “Leases.” The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In June 2016, the FASB released ASU 2016-13, “Financial Instruments – Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2016, the FASB released ASU 2016-15, “Statement of Cash Flows – Classification of Certain Cash Receipts and Cash Payments.” The amendment provides and clarifies guidance on the classification of certain cash receipts and cash payments in the statement of cash flows to eliminate diversity in practice. The Company is required to adopt the standard update in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In October 2016, the FASB released ASU 2016-16, “Income Tax – Intra-Entity Transfers of Assets Other than Inventory.” This standard update improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Early adoption is permitted. The Company is required to adopt the standard in the first quarter of fiscal year 2019.

8

The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In November 2016, the FASB released ASU 2016-18, “Statement of Cash Flows – Restricted Cash.” This standard update requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company is required to adopt this standard in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2017, the FASB released ASU 2017-12, “Targeted Improvements to Accounting for Hedging Activities.” The new guidance is intended to: (1) more closely align hedge accounting with an entity’s risk management strategies, (2) simplify the application of hedge accounting by eliminating the requirement to separately measure and report hedge ineffectiveness, and (3) increase transparency around the scope and results of hedging programs. The Company is required to adopt the standard in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

NOTE 3 — EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s options, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands)
Equity-based compensation expense	$	41,783	$	38,595
Income tax benefit recognized related to equity-based compensation expense	$	13,387	$	10,905

The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis. In the first quarter of fiscal year 2018, the Company adopted ASU 2016-9, “Compensation – Stock Compensation,” as discussed further in Note 2.

9

NOTE 4 — OTHER EXPENSE, NET

The significant components of other expense, net, are as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Interest income	$	20,209		$	12,763
Interest expense	(23,905		)	(41,429		)
Gains on deferred compensation plan related assets, net	3,453			6,172
Foreign exchange (losses) gains, net	(3,000		)	1,219
Other, net	(2,259		)	(1,879		)
	$	(5,502	)	$	(23,154	)

Interest income in the three months ended September 24, 2017, increased compared to the three months ended September 25, 2016, due to longer portfolio duration and higher yield. Interest expense decreased in the September 2017 quarter, compared to the September 2016 quarter, due to the termination of the Term Loan Agreement and mandatory redemption of the Senior Notes due 2023 and 2026 during the December 2016 quarter.

NOTE 5 — INCOME TAX EXPENSE

The Company recorded an income tax expense of $97.0 million for the three months ended September 24, 2017, which yielded an effective tax rate of approximately 14.1%.

The difference between the U.S. federal statutory tax rate of 35% and the Company’s effective tax rate for the three months months ended September 24, 2017, is primarily due to income in lower tax jurisdictions.

The Company is in various stages of examination in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its unrecognized tax benefits as a result of tax examinations or lapses of statute of limitation. The estimated reduction in unrecognized tax benefits may range from $15 million to $50 million.

NOTE 6 — NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, convertible notes, and warrants. Dilutive shares outstanding include the effect of the convertible notes. Refer to Note 11 for additional information regarding the Company’s convertible notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. 

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands, except per share data)
Numerator:
Net income	$	590,690	$	263,835
Denominator:
Basic average shares outstanding	162,141		160,607
Effect of potential dilutive securities:
Employee stock plans	2,514		2,142
Convertible notes	15,151		15,220
Warrants	4,074		2,048
Diluted average shares outstanding	183,880		180,017
Net income per share - basic	$	3.64	$	1.64
Net income per share - diluted	$	3.21	$	1.47

10

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:

	Three Months Ended
	September 24, 2017	September 25, 2016
	(in thousands)
Number of options and RSUs excluded	7	196

Diluted shares outstanding do not include any effect resulting from note hedges associated with the Company’s 2018 Notes as their impact would have been anti-dilutive.

NOTE 7 — FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 11 to the Condensed Consolidated Financial Statements for additional information regarding the fair value of the Company’s Senior Notes and Convertible Notes.

11

The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of September 24, 2017, and June 25, 2017:

	September 24, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	543,990	$	—	$	—		$	543,990	$	537,972	$	—	$	6,018	$	—
Level 1:
Time deposit	693,205		—		—			693,205		443,178		—		250,027		—
Money market funds	1,395,032		—		—			1,395,032		1,395,032		—		—		—
U.S. Treasury and agencies	821,441		265		(2,569		)	819,137		15,648		803,489		—		—
Mutual funds	53,131		3,125		(70		)	56,186		—		—		—		56,186
Level 1 Total	2,962,809		3,390		(2,639		)	2,963,560		1,853,858		803,489		250,027		56,186
Level 2:
Municipal notes and bonds	165,029		322		(21		)	165,330		—		165,330		—		—
U.S. Treasury and agencies	12,798		—		(102		)	12,696		—		12,696		—		—
Government-sponsored enterprises	55,845		—		(322		)	55,523		—		55,523		—		—
Foreign government bonds	67,040		90		(128		)	67,002		—		67,002		—		—
Corporate notes and bonds	2,532,374		4,020		(2,376		)	2,534,018		14,632		2,519,386		—		—
Mortgage backed securities — residential	46,614		63		(116		)	46,561		—		46,561		—		—
Mortgage backed securities — commercial	106,173		40		(275		)	105,938		—		105,938		—		—
Level 2 Total	2,985,873		4,535		(3,340		)	2,987,068		14,632		2,972,436		—		—
Total	$	6,492,672	$	7,925	$	(5,979	)	$	6,494,618	$	2,406,462	$	3,775,925	$	256,045	$	56,186

	June 25, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	551,308	$	—	$	—		$	551,308	$	545,130	$	—	$	6,178	$	—
Level 1:
Time deposit	640,666		—		—			640,666		390,639		—		250,027		—
Money market funds	1,423,417		—		—			1,423,417		1,423,417		—		—		—
U.S. Treasury and agencies	783,848		684		(2,111		)	782,421		8,297		774,124		—		—
Mutual funds	53,247		3,007		—			56,254		—		—		—		56,254
Level 1 Total	2,901,178		3,691		(2,111		)	2,902,758		1,822,353		774,124		250,027		56,254
Level 2:
Municipal notes and bonds	194,575		308		(7		)	194,876		—		194,876		—		—
U.S. Treasury and agencies	12,795		—		(167		)	12,628		—		12,628		—		—
Government-sponsored enterprises	24,502		—		(6		)	24,496		—		24,496		—		—
Foreign government bonds	62,917		219		(114		)	63,022		—		63,022		—		—
Corporate notes and bonds	2,433,622		4,654		(1,840		)	2,436,436		10,051		2,426,385		—		—
Mortgage backed securities — residential	102,760		87		(489		)	102,358		—		102,358		—		—
Mortgage backed securities — commercial	65,828		9		(98		)	65,739		—		65,739		—		—
Level 2 Total	2,896,999		5,277		(2,721		)	2,899,555		10,051		2,889,504		—		—
Total	$	6,349,485	$	8,968	$	(4,832	)	$	6,353,621	$	2,377,534	$	3,663,628	$	256,205	$	56,254

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through

12

consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The Company did not recognize any losses on investments due to other-than-temporary impairments during the three months ended September 24, 2017 or September 25, 2016. Additionally, gross realized gains/(losses) from sales of investments were approximately $0.8 million and $(1.0) million, respectively, in the three months ended September 24, 2017, and $2.6 million and $(0.2) million, respectively, in the three months ended September 25, 2016.

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions:

	September 24, 2017
	Unrealized Losses Less than 12 Months					Unrealized Losses 12 Months or Greater					Total
	Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	660,429	$	(2,671	)	$	—	$	—		$	660,429	$	(2,671	)
Municipal notes and bonds	18,653		(21		)	—		—			18,653		(21		)
Mutual funds	3,122		(70		)	—		—			3,122		(70		)
Government-sponsored enterprises	55,297		(322		)	—		—			55,297		(322		)
Foreign government bonds	33,729		(128		)	—		—			33,729		(128		)
Corporate notes and bonds	1,282,655		(2,376		)	—		—			1,282,655		(2,376		)
Mortgage backed securities — residential	30,210		(93		)	2,006		(23		)	32,216		(116		)
Mortgage backed securities — commercial	98,303		(261		)	2,634		(14		)	100,937		(275		)
	$	2,182,398	$	(5,942	)	$	4,640	$	(37	)	$	2,187,038	$	(5,979	)

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of September 24, 2017:

	Cost		Estimated Fair Value
	(in thousands)
Due in one year or less	$	2,764,552	$	2,764,415
Due after one year through five years	2,987,295		2,986,525
Due in more than five years	143,704		143,502
	$	5,895,551	$	5,894,442

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than twelve months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.

13

Cash Flow Hedges

The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro- denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized.

In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive (loss) and is amortized into income as the hedged item impacts earnings.

At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. Changes in the fair value of foreign exchange options due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the three months ended September 24, 2017 or September 25, 2016 associated with ineffectiveness or forecasted transactions that failed to occur.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value associated with the forward contracts and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of September 24, 2017, the Company had gains of $6.3 millionaccumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next 12 months. Additionally, the Company had a net loss of $1.9 million accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 7.5 years.

Fair Value Hedges

The Company has interest rate contracts whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of other expense, net in our Condensed Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized.

Balance Sheet Hedges

The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense).

14

As of September 24, 2017, the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs:

	Notional Value
	Derivatives Designated as Hedging Instruments:				Derivatives Not Designated as Hedging Instruments:
	(in thousands)
Foreign currency forward contracts
	Buy Contracts		Sell Contracts		Buy Contracts		Sell Contracts
Japanese yen	$	—	$	393,345	$	—	$	282,311
Euro	31,917		—		31,246		—
Korean won	13,536		—		—		84,122
Taiwan dollar	—		—		12,658		—
Swiss franc	—		—		9,375		—
Chinese renminbi	—		—		7,137
Singapore dollar	—		—		4,469		—
	$	45,453	$	393,345	$	64,885	$	366,433
Foreign currency option contracts
	Buy Put		Sell Put		Buy Put(1)		Sell Put
Japanese yen	$	36,036	$	—	$	8,929	$	8,929

(1) Contracts were entered into and designated as cash flow hedges under ASC 815 at contract inception as part of the Company’s cash flow hedge program. The contracts were subsequently de-designated; changes in fair market value subsequent to de-designation effect current earnings.

The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of September 24, 2017, and June 25, 2017 were as follows:

	September 24, 2017						June 25, 2017
	Fair Value of Derivative Instruments (Level 2)						Fair Value of Derivative Instruments (Level 2)
	Asset Derivatives			Liability Derivatives			Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
	(in thousands)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	$	9,598	Accrued expenses and other current liabilities	$	368	Prepaid expense and other assets	$	8,061	Accrued expenses and other current liabilities	$	2,916
Interest rate contracts, short-term	Prepaid expense and other assets	316								Accrued expenses and other current liabilities	2,833
Interest rate contracts, long-term				Other long-term liabilities	13,077					Other long-term liabilities	7,269
Derivatives not designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	109		Accrued expenses and other current liabilities	461		Prepaid expense and other assets	213		Accrued expenses and other current liabilities	342
Total Derivatives		$	10,023		$	13,906		$	8,274		$	13,360

Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of September 24, 2017, the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by $5.1 million, resulting in a net

15

derivative asset of $4.9 million and net derivative liability of $8.8 million. As of June 25, 2017, the potential effect of rights of offset associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $5.9 million, resulting in a net derivative asset of $2.3 million and a net derivative liability of $7.4 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions.

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:

		Three Months Ended September 24, 2017									Three Months Ended September 25, 2016
		Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness			Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness
Derivatives Designated as Hedging Instruments	Location of  Gain (Loss) Recognized  in or  Reclassified into Income	(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income			(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Revenue	$	(9	)	$	(3,806	)	$	2,547		$	(2,913	)	$	(13,605	)	$	705
Foreign Exchange Contracts	Cost of goods sold	2,443			824			(208		)	235			173			(67		)
Foreign Exchange Contracts	Selling, general, and administrative	1,356			714			(117		)	(24		)	(9		)	(21		)
Foreign Exchange Contracts	Other expense, net	—			—			(17		)	—			—			—
Interest Rate Contracts	Other expense, net	—			(31		)	—			—			9			—
		$	3,790		$	(2,299	)	$	2,205		$	(2,702	)	$	(13,432	)	$	617

The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended
		September 24, 2017		September 25, 2016
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Income		Loss Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Other  income	$	2,672	$	(383	)

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company.

16

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

NOTE 8 — INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Raw materials	$	721,352	$	625,600
Work-in-process	200,271		213,066
Finished goods	406,674		394,250
	$	1,328,297	$	1,232,916

NOTE 9 — GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.5 billion and $1.4 billion as of September 24, 2017, and June 25, 2017, respectively. As of September 24, 2017, $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.

Intangible Assets

The following table provides the Company’s intangible assets:

	September 24, 2017							June 25, 2017
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
	(in thousands)
Customer relationships	$	630,257	$	(383,131	)	$	247,126	$	615,164	$	(366,439	)	$	248,725
Existing technology	669,603		(508,983		)	160,620		643,196		(487,056		)	156,140
Patents	36,553		(31,872		)	4,681		36,553		(31,238		)	5,315
Other intangible assets	43,814		(35,882		)	7,932		36,514		(35,699		)	815
Total intangible assets	$	1,380,227	$	(959,868	)	$	420,359	$	1,331,427	$	(920,432	)	$	410,995

The Company recognized $39.3 million and $38.7 million in intangible asset amortization expense during the three months ended September 24, 2017, and September 25, 2016, respectively. Refer to Note 15 - Business Combinations for additional information regarding intangible assets acquired during the three months ended September 24, 2017.

The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 24, 2017, was as follows:

Fiscal Year	Amount
	(in thousands)
2018 (remaining 9 months)	$	121,147
2019	123,429
2020	58,296
2021	55,611
2022	51,801
Thereafter	10,075
	$	420,359

17

NOTE 10 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Accrued compensation	$	510,583	$	447,363
Warranty reserves	168,337		161,981
Income and other taxes payable	145,022		95,127
Dividend payable	73,127		72,738
Other	181,929		192,152
	$	1,078,998	$	969,361

NOTE 11 — LONG-TERM DEBT AND OTHER BORROWINGS

As of September 24, 2017, and June 25, 2017, the Company’s outstanding debt consisted of the following:

	September 24, 2017						June 25, 2017
	Amount (in thousands)				Effective Interest Rate		Amount (in thousands)				Effective Interest Rate
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes")	$	238,367		(1)	5.27	%	$	447,436		(2)	5.27	%
Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes")	500,000				2.88	%	500,000				2.88	%
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000				2.95	%	800,000				2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000				3.87	%	500,000				3.87	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	538,468			(1)	4.28	%	631,074			(2)	4.28	%
Total debt outstanding, at par	2,576,835						2,878,510
Unamortized discount	(145,241		)				(178,589		)
Fair value adjustment - interest rate contracts	(12,761		)				(10,102		)
Unamortized bond issuance costs	(2,798		)				(3,161		)
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658
Reported as:
Current portion of long-term debt	$	639,252		(3)			$	907,827		(3)
Long-term debt	1,776,783						1,778,831
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658

____________________________

⁽¹⁾ As of September 24, 2017, these notes were convertible at the option of the bondholder, as a result of the condition described in (3) below. Upon closure of the conversion period, the 2041 Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity.

⁽²⁾ As of June 25, 2017, these notes were convertible at the option of the bond holder, as a result of the condition described in (3) below.

⁽³⁾ As of the report date, the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets.

Convertible Senior Notes

In May 2011, the Company issued and sold $450 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 1.25%, on a semi-annual basis on May 15 and November 15 of each year.

In June 2012, with the acquisition of Novellus Systems, Inc. (“Novellus”), the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may

18

require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.

The Company separately accounts for the liability and equity components of the Convertible Notes. The initial debt components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.

Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of Convertible Note conversions in the three months ended September 24, 2017, was approximately $301.7 million.

Selected additional information regarding the Convertible Notes outstanding as of September 24, 2017, and June 25, 2017, is as follows:

	September 24, 2017				June 25, 2017
	2018 Notes		2041 Notes		2018 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	92,388	$	157,210	$	89,604	$	156,374
Carrying amount of temporary equity component, net of tax	$	5,816	$	131,180	$	15,186	$	154,675
Remaining amortization period (years)	0.6		23.6		0.8		23.8
Fair Value of Notes (Level 2)	$	697,829	$	2,805,294
Conversion rate (shares of common stock per $1,000 principal amount of notes)	16.6142		29.8160
Conversion price (per share of common stock)	$	60.19	$	33.54
If-converted value in excess of par value	$	461,533	$	2,298,926
Estimated share dilution using average quarterly stock price $159.71 per share	2,468		12,683

Convertible Note Hedges and Warrants

Concurrent with the issuance of the 2018 Notes the Company purchased a convertible note hedge and sold warrants. The warrants settlement is contractually defined as net share settlement. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. As of September 24, 2017, the warrants associated with the 2018 Notes had not been exercised and remained outstanding.

In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. During the period ended September 24, 2017 the note hedge was partially settled, resulting in the receipt of approximately 2,092,000 shares.

19

The following table presents the details of the warrants and convertible note hedge arrangements as of September 24, 2017:

	2018 Notes
	(shares in thousands)
Warrants:
Underlying shares	7,476
Estimated share dilution using average quarterly stock price $159.71 per share	4,074
Exercise price	$	72.69
Expiration date range	August 15 - October 24, 2018
Convertible Note Hedge:
Number of shares available from counterparties	3,960
Exercise price	$	60.19

Senior Notes

On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March, 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March, 2025 (the “2025 Notes”, together with the 2020 Notes, the “Senior Notes”). The Company pays interest at an annual rate of 2.75% and 3.80%, on the 2020 Notes and 2025 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year. During the year ended June 26, 2016, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 7 for additional information regarding these interest rate contracts.

The Company may redeem the Senior Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before February 15, 2020, for the 2020 Notes and before December 15, 2024, for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020, for the 2020 Notes and on or after December 24, 2024, for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest.

On June 7, 2016, The Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”, together with the 2020 and 2025 Notes, the “Senior Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year.

The Company may redeem the 2021 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes and accrued and unpaid interest before May 15, 2021. The Company may redeem the 2021 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the 2021 Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.

Selected additional information regarding the Senior Notes outstanding as of September 24, 2017, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2020 Notes	2.5	$	507,915
2021 Notes	3.7	$	810,384
2025 Notes	7.5	$	518,625

20

Interest Cost

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the three months ended September 24, 2017, and September 25, 2016.

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Contractual interest coupon	$	17,956		$	34,712
Amortization of interest discount	4,104			5,914
Amortization of issuance costs	485			918
Effect of interest rate contracts, net	(349		)	(1,058		)
Total interest cost recognized	$	22,196		$	40,486

Revolving Credit Facility

On November 10, 2015, the Company entered into an Amendment and Restatement Agreement (as amended on April 26, 2016, by Amendment No. 1 to the Amended and Restated Credit Agreement, and as further amended, restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates the Company’s prior unsecured Credit Agreement, dated March 12, 2014 (as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from $300.0 million to $750.0 million with a syndicate of lenders. It includes an expansion option, subject to certain requirements, for us to request an increase in the facility of up to an additional $250.0 million, for a potential total commitment of $1.0 billion. Proceeds from the credit facility can be used for general corporate purposes. The facility matures on November 10, 2020.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5% in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default that are substantially similar to those in the Amended and Restated Term Loan Agreement. As of September 24, 2017, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

On October 13, 2017, the Company entered into Amendment No. 2 to Amended and Restated Credit Agreement (the “2nd Amendment”), among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Company’s Credit Agreement (as amended by the 2nd Amendment, the “Amended Credit Agreement”).

Among other things, the Amended Credit Agreement provides for a $500 million increase to the Company’s revolving credit facility, from $750 million under the Credit Agreement to $1.25 billion under the Amended Credit Agreement. The Amended Credit Agreement also modifies the date of maturity of the revolving credit facility from November 10, 2020 to October 13, 2022. The Amended Credit Agreement provides for an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600 million, for a potential total commitment of $1.85 billion. Other than as disclosed in this paragraph, the material terms of the Amended Credit Agreement are substantially the same as the Credit Agreement.

NOTE 12 — COMMITMENTS AND CONTINGENCIES

Operating Leases and Related Guarantees

The Company leases the majority of its administrative, research and development (“R&D”) and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

21

The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company was required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of September 24, 2017.

During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than approximately $220.4 million; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $250.0 million, in the aggregate.

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into certain insurance contracts that are intended to limit its exposure to such indemnifications. As of September 24, 2017, the Company had not recorded any liability in connection with these indemnifications, as it does not believe that it is probable that any amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of September 24, 2017, the maximum potential amount of future payments that it could be required to make under these arrangements and letters of credit was $20.6 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Balance at beginning of period	$	161,981		$	100,321
Warranties issued during the period	48,790			34,855
Settlements made during the period	(44,053		)	(32,228		)
Changes in liability for pre-existing warranties	1,619			278
Balance at end of period	$	168,337		$	103,226

Legal proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual for litigation or other contingencies related to existing legal proceedings.

NOTE 13 — STOCK REPURCHASE PROGRAM

In November 2016, the Board of Directors authorized the repurchase of up to $1.0 billion of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases are funded using the Company’s on-

22

shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 25, 2017						$	282,141
Quarter ended September 24, 2017	1,779	$	157,938	$	158.40	$	124,203

(1) Average price paid per share excludes effect of accelerated share repurchases; see additional disclosure below regarding our accelerated share repurchase activity during the fiscal year.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three months ended September 24, 2017, the Company acquired 11 thousand shares at a total cost of $1.8 million which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

On April 19, 2017, the Company entered into two separate accelerated share repurchase agreements (collectively, the “ASR”) with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 2,570,000 shares, which represented 70% of the prepayment amount divided by the Company’s closing stock price on April 19, 2017. The total number of shares to be received under the ASR was based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Following the fiscal year end, the counterparties designated June 30, 2017 as the termination date, at which time the Company settled the ASR. Approximately 780,000 shares were received at final settlement, which resulted in a weighted-average share price of approximately $149.16 for the transaction period.

NOTE 14 — ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows:

	Accumulated Foreign Currency Translation Adjustment				Accumulated Unrealized  Holding Gain (Loss) on Cash flow hedges				Accumulated Unrealized  Holding Gain (Loss) on Available-For-Sale  Investments				Accumulated Unrealized  Components of Defined  Benefit Plans			Total
	(in thousands)
Balance as of June 25, 2017	$	(42,371	)		$	(811	)		$	1,106			$	(19,624	)	$	(61,700	)
Other comprehensive income (loss) before reclassifications	7,886				3,062				(1,727		)		(2,356		)	6,865
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income	(17		)	(1)	2,188			(2)	(123		)	(1)	—			2,048
Net current-period other comprehensive income (loss)	$	7,869			$	5,250			$	(1,850	)		$	(2,356	)	$	8,913
Balance as of September 24, 2017	$	(34,502	)		$	4,439			$	(744	)		$	(21,980	)	$	(52,787	)

(1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.

(2) Amount of after tax gain reclassified from AOCI into net income located in revenue: $3,383 loss; cost of goods sold: $678 gain; selling, general, and administrative expenses: $537 gain; and other income and expense: $20 loss.

23

NOTE 15 – BUSINESS COMBINATIONS

On August 28, 2017, the Company completed the acquisition of the outstanding shares of Coventor, Inc. (“Coventor”), a privately-held company that is a provider of simulation and modeling solutions for semiconductor process technology, micro-electromechanical systems (MEMS), and the Internet of Things, for a total purchase consideration of $137.6 million.

The following table represents the preliminary purchase price allocation and summarizes the aggregate estimated fair value of the net assets acquired on the closing date of the acquisition:

	Preliminary Purchase Price Allocation
	(In thousands)
Intangible assets	$	48,500
Assets acquired (including cash of $8.7 million)	12,796
Goodwill	97,832
Liabilities assumed	(21,517		)
Fair value of net assets acquired	$	137,611

The preliminary fair values of net tangible and intangible assets acquired were based on preliminary valuations, and management’s estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The primary area that remains open relates to the fair value of intangible assets, certain tangible assets and liabilities assumed and income taxes. The Company expects to continue to obtain information to assist us in determining the fair value of the net assets acquired during the measurement period.

The operating results of the acquired entity, from the date of acquisition, have been included in the Company’s Condensed Consolidated Financial Statements for the three months ended September 24, 2017. Goodwill represents the excess of the purchase price over the net tangible and identifiable intangible assets acquired. None of the goodwill recognized is deductible for income tax purposes.

The identified intangible assets assumed in the acquisition of Coventor were recognized as follows based upon their fair values as of August 28, 2017:

	Fair Value		Weighted-Average Estimated Useful Life
	(In thousands)		(In years)
Existing technology	$	26,200	6.0
Customer relationships	15,000		6.0
Trade names and other intangible assets	7,300		6.4
Total identified intangible assets	$	48,500	6.0

Acquired existing technology represents the fair value of products that have reached technological feasibility and are a part of Coventor’s product offerings and customer relationships represent the fair values of the underlying relationships and agreements with Coventor’s customers.

24

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS

With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified as forward-looking, by use of phrases and words such as “believe,” “anticipate,” “expect,” “plan,” “aim,” “may,” “should,” “could,” “would,” “continue,” and other future-oriented terms. The identification of certain statements as “forward-looking” does not mean that other statements not specifically identified are not forward-looking. Forward-looking statements include but are not limited to statements that relate to: trends and opportunities in the global economic environment and the semiconductor industry; the anticipated levels of, and rates of change in, future shipments, margins, market share, capital expenditures, research and development expenditures, international sales, revenue and operating expenses generally; management’s plans and objectives for our current and future operations and business focus; volatility in our quarterly results; customer and end user requirements and our ability to satisfy those requirements; customer capital spending and their demand for our products, and the reliability of indicators of change in customer spending and demand; the effect of variability in our customers’ business plans on demand for our equipment and services; changes in demand for our products and in our market share resulting from, among other things, increases in our customers’ proportion of capital expenditure (with respect to certain technology inflections); hedging transactions; our ability to defend our market share and to gain new market share; our ability to obtain and qualify alternative sources of supply; factors that affect our tax rates; anticipated growth in the industry and the total market for wafer fabrication equipment and our growth relative to such growth; the success of joint development and collaboration relationships with customers, suppliers, or others; outsourced activities; the role of component suppliers in our business; our leadership and competency, and their ability to facilitate innovation; our ability to continue to, including the underlying factors that, create sustainable differentiation; the resources invested to comply with evolving standards and the impact of such efforts; the estimates we make, and the accruals we record, in order to implement our critical accounting policies (including but not limited to the adequacy of prior tax payments, future tax liabilities, and the adequacy of our accruals relating to them); our access to capital markets; our intention to pay quarterly dividends and the amounts thereof, if any; our ability and intention to repurchase our shares; our ability to manage and grow our cash position; and the sufficiency of our financial resources to support future business activities (including but not limited to operations, investments, debt service requirements, and capital expenditures). Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value, and effect, including without limitation those discussed below under the heading “Risk Factors” within Part II Item 1A and elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (“SEC”), such as our annual report on Form 10-K for the year ended June 25, 2017 (our “2017 Form 10-K”), and our current reports on Form 8-K. Such risks, uncertainties, and changes in condition, significance, value, and effect could cause our actual results to differ materially from those expressed in this report and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We do not undertake any obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.

Documents To Review In Connection With Management’s Discussion and Analysis Of Financial Condition and Results Of Operations

For a full understanding of our financial position and results of operations for the three months ended September 24, 2017, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations below, you should also read the Condensed Consolidated Financial Statements and notes presented in this Form 10-Q and the financial statements and notes in our 2017 Form 10-K.

EXECUTIVE SUMMARY

Lam Research is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong global presence with core competencies in areas like nanoscale applications enablement, chemistry, plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are designed to help our customers build smaller, faster, and better performing devices that are used in a variety of electronic products, including mobile phones, personal computers, servers, wearables, automotive devices, storage devices, and networking equipment. Our vision is to realize full value from natural technology extensions of our company.

25

Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such as non-volatile memory (“NVM”), DRAM memory, and logic devices. We aim to increase our strategic relevance with our customers by contributing more to their continued success. Our core technical competency is integrating hardware, process, materials, software, and process control enabling results on the wafer.

Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-effective.

Demand from cloud computing, Internet of Things, and other markets is driving the need for increasingly powerful and cost-efficient semiconductors. At the same time, there are growing technical challenges with traditional two-dimensional scaling. These trends are driving significant inflections in semiconductor manufacturing, such as the increasing importance of vertical scaling strategies like 3D architectures as well as multiple patterning to enable shrinks.

We believe we are in a strong position with our leadership and competency in deposition, etch, and single-wafer clean to facilitate some of the most significant innovations in semiconductor device manufacturing. Several factors create opportunity for sustainable differentiation for us: our focus on research and development, with a breadth of programs across sustaining engineering, product and process development, and concept and feasibility; our ability to effectively leverage cycles of learning from our broad installed base; and our collaborative focus with ecosystem partners.

During the most recent quarter, demand for our products remained stable with increased investments from our logic customers and continued investments from our memory customers. Technology inflections in our industry, including NVM, multiple patterning, FinFET and advanced packaging have led to an increase in the served addressable market for our products in deposition, etch, single-wafer clean, and customer service business. We believe that demand for our products and services should increase faster than overall spending on wafer fabrication equipment, as the proportion of customers’ capital expenditures rises in these technology inflection areas and we continue to gain market share.

We acquired the outstanding shares of Coventor, Inc., a privately-held company, on August 28, 2017, as further discussed in Note 15 of our Condensed Consolidated Financial Statements. The results of the acquired business are included in our Condensed Consolidated Financial Statements.

The following summarizes certain key financial information for the periods indicated below:

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands, except per share data and percentages)
Revenue	$	2,478,140		$	2,344,907		$	1,632,419
Gross margin	$	1,149,343		$	1,068,961		$	716,197
Gross margin as a percent of total revenue	46.4		%	45.6		%	43.9		%
Total operating expenses	$	456,121		$	461,022		$	400,250
Net income	$	590,690		$	526,424		$	263,835
Diluted net income per share	$	3.21		$	2.82		$	1.47

In the September 2017 quarter, revenue increased compared to the June 2017 quarter as modest shipment declines were offset by timing of revenue recognition. Gross margin as a percentage of revenue in the September 2017 quarter increased as compared to the June 2017 quarter primarily due to favorable customer and product mix. Operating expenses in the September 2017 quarter decreased compared to the June 2017 quarter mainly due to lower spend associated with business process reengineering partially offset by acquisition-related costs.

Our cash and cash equivalents, investments, and restricted cash and investments balances increased slightly to $6.4 billion as of September 24, 2017, in comparison to the same balance as of June 25, 2017. Cash generated by operations was approximately $858 million during the September 2017 quarter. We used cash during the September 2017 quarter for approximately $302 million of principal payments on debt, primarily related to our convertible notes, $155 million of share repurchases, including net share settlement on employee stock-based compensation, $116 million for business acquisitions, $73 million of dividends paid to our stockholders, and $60 million of capital expenditures. Employee headcount as of September 24, 2017, was approximately 9,800.

26

RESULTS OF OPERATIONS

Shipments

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
Shipments (in millions)	$	2,382		$	2,543		$	1,708
Korea	38		%	36		%	28		%
Japan	19		%	21		%	11		%
Taiwan	15		%	14		%	26		%
China	10		%	16		%	11		%
United States	8		%	8		%	8		%
Southeast Asia	5		%	2		%	11		%
Europe	5		%	3		%	5		%

Shipments for the September 2017 quarter decreased6% from the June 2017 and increased 39% from the September 2016 quarter levels, reflecting timing of customer demand for semiconductor equipment. The increase in the September 2017 quarter from the September 2016 quarter was mainly driven by investments from our memory and logic customers.

The percentages of system shipments to each of the markets we serve were as follows for the periods presented:

	Three Months Ended
	September 24, 2017		June 25, 2017		September 25, 2016
Memory	66	%	73	%	56	%
Foundry	21	%	22	%	36	%
Logic/integrated device manufacturing	13	%	5	%	8	%

Revenue

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
Revenue (in millions)	$	2,478		$	2,345		$	1,632
Korea	38		%	38		%	23		%
Japan	20		%	17		%	15		%
Taiwan	14		%	16		%	26		%
China	14		%	16		%	14		%
United States	6		%	9		%	7		%
Southeast Asia	5		%	1		%	12		%
Europe	3		%	3		%	3		%

Revenue for the September 2017 quarter increased6% from the June 2017 quarter and increased52% compared to the September 2016 quarter, as modest shipment declines were offset by timing of revenue recognition. Our deferred revenue balance decreased to $938 million as of September 24, 2017, compared to $966 million as of June 25, 2017, as a result of timing of shipments and revenue recognition. Our deferred revenue balance does not include system shipments to Japanese customers, for which title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The estimated future revenue value from shipments to Japanese customers was approximately $344 million as of September 24, 2017, and $397 million as of June 25, 2017.

27

Gross Margin

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands, except percentages)
Gross margin	$	1,149,343		$	1,068,961		$	716,197
Percent of total revenue	46.4		%	45.6		%	43.9		%

Gross margin as a percentage of revenue in the September 2017 quarter increased compared to the June 2017 and the September 2016 quarter primarily due to favorable changes in customer and product mix.

Research and Development

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands, except percentages)
Research & development (“R&D”)	$	275,078		$	285,712		$	235,240
Percent of total revenue	11.1		%	12.2		%	14.4		%

We continued to make significant R&D investments focused on leading-edge deposition, plasma etch, single-wafer clean and other semiconductor manufacturing requirements. The spending in the September 2017 quarter decreased compared to the June 2017 quarter mainly due to decreases of $8 million in supplies, $5 million in variable compensation offset by immaterial other expense increases. The increase in R&D expenses during the September 2017 quarter compared to the same period in the prior year was mainly due to increases of $24 million in employee compensation from higher headcount, $12 million in supplies, $2 million in depreciation and amortization, and $2 million of employee-related costs, offset by a $3 million decrease in costs associated with a campus consolidation realized in September 2016.

Selling, General, and Administrative

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands, except percentages)
Selling, general, and administrative	$	181,043		$	175,310		$	165,010
Percent of total revenue	7.3		%	7.5		%	10.1		%

The increase in selling, general, and administrative (“SG&A”) expenses during the September 2017 quarter compared to the June 2017 quarter was primarily due to increases of $3 million in facilities cost, $2 million increase in depreciation and amortization, $2 million increases in outside services, $1 million increase in Coventor acquisition-related costs offset by a $4 million reduction in business process reengineering costs. The increase in SG&A expenses during the September 2017 quarter compared to the same period in the prior year was primarily due to increases of $8 million in employee compensation from higher headcount, and $5 million outside services.

28

Other Expense, Net

Other expense, net consisted of the following:

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands)
Interest income	$	20,209		$	17,805		$	12,763
Interest expense	(23,905		)	(24,912		)	(41,429		)
Gains on deferred compensation plan related assets, net	3,453			5,749			6,172
Foreign exchange (losses) gains, net	(3,000		)	(3,479		)	1,219
Other, net	(2,259		)	393			(1,879		)
	$	(5,502	)	$	(4,444	)	$	(23,154	)

Interest income increased in the September 2017 quarter compared to the June 2017 quarter as a result of higher cash and investment balances, longer portfolio duration, and higher yield. Interest income increased in the September 2017 quarter compared to the September 2016 quarter as a result of an increase in yield.

Interest expense decreased in the September 2017 quarter compared to the June 2017 quarter due to the conversions of the 2018 and 2041 Convertible Notes. Interest expense decreased in the September 2017 quarter compared to the September 2016 quarter due to the termination of the Term Loan Agreement and mandatory redemption of the Senior Notes due 2023 and 2026 during the December 2016 quarter.

Changes in the market value of securities in the portfolio drove the noted variability in the gains/losses on assets related to obligations under our deferred compensation plan.

Foreign exchange losses in the September 2017 quarter were lower in comparison to losses in the June 2017 quarter but were higher in comparison to gains in the September 2016 quarter due to unfavorable currency movements against our unhedged balance sheet exposures.

Other, net was higher during the September 2017 quarter, compared to the June 2017 quarter, primarily due to net losses on equity investments and increased charitable contributions.

Income Tax Expense

Our provision for income taxes and effective tax rate for the periods indicated were as follows:

	Three Months Ended
	September 24, 2017			June 25, 2017			September 25, 2016
	(in thousands, except percentages)
Income tax expense	$	97,030		$	77,071		$	28,958
Effective tax rate	14.1		%	12.8		%	9.9		%

The increase in the effective tax rate for the September 2017 quarter compared to the June 2017 quarter was due to the change in level and proportion of income in higher and lower tax jurisdictions and recognition of previously unrecognized tax benefits from lapse of statutes of limitation in the June 2017 quarter.

The increase in the effective tax rate for the September 2017 quarter compared to the September 2016 quarter was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions and an increase in deferred tax accrual related to increase in foreign earnings to be repatriated in the September 2017 quarter.

International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States at rates that are generally lower than in the United States. Please refer to Note 6 of the notes to our Consolidated Financial Statements in our 2017 Form 10-K for additional information.

29

Uncertain Tax Positions

We reevaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. Any change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

A critical accounting policy is defined as one that has both a material impact on our financial condition and results of operations and requires us to make difficult, complex and/or subjective judgments, often as a result of the need to make estimates about matters that are inherently uncertain. The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make certain judgments, estimates and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We base our estimates and assumptions on historical experience and on various other assumptions we believe to be applicable and evaluate them on an ongoing basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates, which could have a material impact on our business, results of operations, and financial condition. Our critical accounting estimates include:

• the recognition and valuation of revenue from multiple-element arrangements, which impacts revenue;

• the valuation of inventory, which impacts gross margin;

• the valuation of warranty reserves, which impacts gross margin;

• the valuation of equity-based compensation expense, including forfeiture estimates, which impacts both gross margin and operating expenses;

• the recognition and measurement of current and deferred income taxes, including the measurement of uncertain tax positions, which impact our provision for income tax expenses; and

• the valuation and recoverability of long-lived assets, which impacts gross margin and operating expenses when we record asset impairments or accelerate their depreciation or amortization.

We believe that the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of our consolidated financial statements regarding the critical accounting estimates indicated above.

Revenue Recognition: We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred and title has passed or services have been rendered, the selling price is fixed or determinable, collection of the receivable is reasonably assured, and we have received customer acceptance or are otherwise released from our customer acceptance obligations. If terms of the sale provide for a lapsing customer acceptance period, we recognize revenue upon the expiration of the lapsing acceptance period or customer acceptance, whichever occurs first. If the practices of a customer do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, we recognize revenue when it can be reliably demonstrated that the delivered system meets all of the agreed-to customer specifications. In situations with multiple deliverables, we recognize revenue upon the delivery of the separate elements to the customer and when we receive customer acceptance or are otherwise released from our customer acceptance obligations. We allocate revenue from multiple-element arrangements among the separate elements using their relative selling prices, based on our best estimate of selling price. Our sales arrangements do not include a general right of return. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items. We generally recognize revenue related to sales of spare parts and system upgrade kits upon shipment. We generally recognize revenue related to services upon completion of the services requested by a customer order. We recognize revenue for extended maintenance service contracts with a fixed payment amount on a straight-line basis over the term of the contract. When goods or services have been delivered to the customer, but all conditions for revenue recognition have not been met, deferred revenue and deferred costs are recorded in deferred profit on our Consolidated Balance Sheet.

Inventory Valuation: Our policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. Estimates of market value include but are not limited to management’s forecasts related to our future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, and possible alternative uses. If future customer demand or market conditions are less favorable than our projections, additional inventory write-downs may be required and would be reflected in cost of goods sold in the period in which we make the revision.

30

Warranty: We record a provision for estimated warranty expenses to cost of sales for each system when we recognize revenue. We periodically monitor the performance and cost of warranty activities, if actual costs incurred are different than our estimates, we may recognize adjustments to provisions in the period in which those differences arise or are identified. We do not maintain general or unspecified reserves; all warranty reserves are related to specific systems.

Equity-based Compensation: Employee Stock Purchase Plan (“ESPP”) and Employee Stock Plans: We determine the fair value of our restricted stock units (“RSUs”), excluding market-based performance RSUs, based upon the fair market value of our Common Stock at the date of grant, discounted for dividends. We estimate the fair value of our market-based performance RSUs using a Monte Carlo simulation model at the date of the grant. We estimate the fair value of our stock options and ESPP awards using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions, including expected stock price volatility and the estimated life of each award. We amortize the fair value of equity-based awards over the vesting periods of the award and we have elected to use the straight-line method of amortization. We estimate expected equity award forfeitures based on historical forfeiture rate activity and expected future employee turnover. We recognize the effect of adjustments made to the forfeiture rate, if any in the period that we change the forfeiture estimate.

Income Taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at this time. In the event that we determine that we would not be able to realize all or part of our net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. Likewise, if we later determine that it is more likely than not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.

We recognize the benefit from a tax position only if it is more likely than not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Long-lived assets: We review goodwill at least annually for impairment. If certain events or indicators of impairment occur between annual impairment tests, we will perform an impairment test at that date. In testing for a potential impairment of goodwill, we: (1) allocate goodwill to the reporting units to which the acquired goodwill relates; (2) estimate the fair value of our reporting units; and (3) determine the carrying value (book value) of those reporting units. Prior to this allocation of the assets to the reporting units, we assess long-lived assets for impairment. Furthermore, if the estimated fair value of a reporting unit is less than the carrying value, we must estimate the fair value of all identifiable assets and liabilities of that reporting unit, in a manner similar to a purchase price allocation for an acquired business. This can require independent valuations of certain internally generated and unrecognized intangible assets such as in-process R&D and developed technology. Only after this process is completed can the amount of goodwill impairment, if any, be determined. In our goodwill impairment process we first assess qualitative factors to determine whether it is necessary to perform a quantitative analysis. We do not calculate the fair value of a reporting unit unless we determine, based on a qualitative assessment, that it is more likely than not that the reporting unit’s fair value is less than its carrying amount.

The process of evaluating the potential impairment of goodwill is subjective and requires significant judgment at many points during the analysis. We determine the fair value of our reporting units by using an income approach. Under the income approach, we determine fair value based on estimated future cash flows of each reporting unit, discounted by an estimated weighted-average cost of capital, which reflects the overall level of inherent risk of a reporting unit and the rate of return an outside investor would expect to earn.

In estimating the fair value of a reporting unit, we make estimates and judgments about the future cash flows of our reporting units, including estimated growth rates and assumptions about the economic environment. Although our cash flow forecasts are based on assumptions that are consistent with the plans and estimates we are using to manage the underlying businesses, there is significant judgment involved in determining the cash flows attributable to a reporting unit. In addition, we make certain judgments about allocating shared assets to the estimated balance sheets of our reporting units. Changes in judgment on these assumptions and estimates could result in a goodwill impairment charge.

31

As a result, several factors could result in an impairment of a material amount of our goodwill balance in future periods, including but not limited to: (1) weakening of the global economy, weakness in the semiconductor equipment industry, or our failure to reach internal forecasts, which could impact our ability to achieve our forecasted levels of cash flows and reduce the estimated discounted cash flow value of our reporting units; and (2) a decline in our Common Stock price and resulting market capitalization, to the extent we determine that the decline is sustained and indicates a reduction in the fair value of our reporting units below their carrying value. Further, the value assigned to intangible assets, other than goodwill, is based on estimates and judgments regarding expectations such as the success and lifecycle of products and technology acquired. If actual product acceptance differs significantly from the estimates, we may be required to record an impairment charge to write down the asset to its realizable value.

For other long-lived assets, we routinely consider whether indicators of impairment are present. If such indicators are present, we determine whether the sum of the estimated undiscounted cash flows attributable to the assets is less than their carrying value. If the sum is less, we recognize an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. We recognize an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The fair value of the asset then becomes the asset’s new carrying value, which we depreciate over the remaining estimated useful life of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our condensed consolidated financial statements, see Note 2, “Recent Accounting Pronouncements,” of our Condensed Consolidated Financial Statements, included in Part 1 of this report.

LIQUIDITY AND CAPITAL RESOURCES

Total gross cash and cash equivalents, investments, and restricted cash and investments (together comprising total cash and investments) were $6.4 billion at September 24, 2017 compared to $6.3 billion as of June 25, 2017. Approximately $5.4 billion and $4.8 billion of our total cash and investments as of September 24, 2017, and June 25, 2017, respectively, was held outside the United States in our foreign subsidiaries, the majority of which is held in U.S. dollars and substantially all of which would be subject to tax at U.S. rates if it were to be repatriated.

Cash Flows from Operating Activities

Net cash provided by operating activities of $858.3 million during the three months ended September 24, 2017, consisted of (in millions):

Net income	$	590.7
Non-cash charges:
Depreciation and amortization	79.1
Equity-based compensation	41.8
Deferred income taxes	43.2
Amortization of note discounts and issuance costs	4.6
Changes in operating asset and liability accounts	92.3
Other	6.6
	$	858.3

Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in inventories of $107.1 million, and prepaid expense and other assets of $44.9 million and decreases in trade accounts payable of $13.2 million and deferred profit of $9.8 million. The uses of cash are offset by sources of cash resulting from decreases in accounts receivable of $145.0 million, and increases in accrued expenses and other liabilities of $122.3 million.

Cash Flows from Investing Activities

Net cash used for investing activities during the three months ended September 24, 2017, was $303.9 million, primarily consisting of net purchases of available-for-sale securities of $117.8 million, business acquisition of $115.6 million, and capital expenditures of $60.1 million.

32

Cash Flows from Financing Activities

Net cash used for financing activities during the three months ended September 24, 2017, was $528.8 million, primarily consisting of $301.7 million of cash paid for debt extinguishment, $155.4 million in treasury stock repurchases, $72.7 million of dividends paid, partially offset by $1.0 million of stock issuance and treasury stock reissuances associated with our employee stock-based compensation plans.

Liquidity

Given that the semiconductor equipment industry is highly competitive and has historically experienced rapid changes in demand, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Anticipated cash flows from operations based on our current business outlook, combined with our current levels of cash, cash equivalents, and short-term investments as of September 24, 2017, are expected to be sufficient to support our anticipated levels of operations, investments, debt service requirements, capital expenditures, capital redistributions, and dividends through at least the next 12 months. However, uncertainty in the global economy and the semiconductor industry, as well as disruptions in credit markets, have in the past, and could in the future, impact customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers, and creditors.

Under certain circumstances, our Convertible Notes may be converted into shares of our Common Stock. During the quarter ended September 24, 2017, approximately $301.7 million principle value of Convertible Notes were converted. We anticipate that conversions may continue in the coming quarters as the 2018 Notes approach maturity. We expect to have sufficient levels of cash, cash equivalents, and short term investments to fund the near-term settlement of these Convertible Notes.

On October 13, 2017, we entered into Amendment No. 2 to Amended and Restated Credit Agreement (the “2nd Amendment”), among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Company’s Credit Agreement (as amended by the 2nd Amendment, the “Amended Credit Agreement”).

Among other things, the Amended Credit Agreement provides for a $500 million increase to the Company’s revolving credit facility, from $750 million under the Credit Agreement to $1.25 billion under the Amended Credit Agreement. The Amended Credit Agreement also modifies the date of maturity of the revolving credit facility from November 10, 2020 to October 13, 2022. The Amended Credit Agreement provides for an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600 million, for a potential total commitment of $1.85 billion. Other than as disclosed in this paragraph, the material terms of the Amended Credit Agreement are substantially the same as the Credit Agreement.

In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances in the United States and offshore, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, given the possibility of changes in market conditions or other occurrences, there can be no certainty that such funding will be available in needed quantities or on terms favorable to us.

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

For financial market risks related to changes in interest rates, marketable equity security prices, and foreign currency exchange rates, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in our 2017 Form 10-K. Other than noted below, our exposure related to market risk has not changed materially since June 25, 2017. All of the potential changes noted below are based on sensitivity analysis performed on our financial position as of September 24, 2017. Actual results may differ materially.

Fixed Income Securities

Our investments in various interest earning securities carry a degree of market risk for changes in interest rates. At any time, a sharp rise in interest rates could have a material adverse impact on the fair value of our fixed income investment portfolio. Conversely, declines in interest rates could have a material adverse impact on interest income for our investment portfolio. We target to maintain a conservative investment policy, which focuses on the safety and preservation of our capital by limiting default risk, market risk, reinvestment risk, and concentration risk.

33

The following table presents the hypothetical fair values of fixed income securities that would result from selected potential decreases and increases in interest rates. Market changes reflect immediate hypothetical parallel shifts in the yield curve of plus or minus 50 basis points (“BPS”), 100 BPS, and 150 BPS. The hypothetical fair values as of September 24, 2017, were as follows:

	Valuation of Securities Given an Interest Rate Decrease of X Basis Points						Fair Value as of September 24, 2017		Valuation of Securities Given an Interest Rate Increase of X Basis Points
	(150 BPS)		(100 BPS)		(50 BPS)		0.00%		50 BPS		100 BPS		150 BPS
	(in thousands)
Time deposit	$	693,205	$	693,205	$	693,205	$	693,205	$	693,205	$	693,205	$	693,205
U.S. Treasury and agencies	860,113		850,957		841,399		831,833		822,169		812,508		802,848
Municipal notes and bonds	166,973		166,847		166,139		165,330		164,522		163,713		162,905
Government-sponsored enterprises	57,316		56,719		56,121		55,523		54,924		54,326		53,727
Foreign government bonds	69,049		68,367		67,684		67,002		66,320		65,638		64,956
Bank and corporate notes	2,599,697		2,577,869		2,555,944		2,534,018		2,512,095		2,490,174		2,468,255
Mortgage backed securities - residential	47,992		47,530		47,046		46,561		46,077		45,591		45,106
Mortgage backed securities - commercial	110,143		108,741		107,339		105,938		104,537		103,137		101,738
Total	$	4,604,488	$	4,570,235	$	4,534,877	$	4,499,410	$	4,463,849	$	4,428,292	$	4,392,740

We mitigate default risk by investing in high credit quality securities and by positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to achieve portfolio liquidity and maintain a prudent amount of diversification.

ITEM 4. Controls and Procedures

Design of Disclosure Controls and Procedures and Internal Control over Financial Reporting

We maintain disclosure controls and procedures and internal control over final reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.

Disclosure Controls and Procedures

As required by Exchange Act Rule 13a-15(b), as of September 24, 2017, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer, along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

34

Effectiveness of Controls

While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. Legal Proceedings

While we are not currently a party to any legal proceedings that we believe are material, we are either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. We accrue for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, we do not believe that a material loss from known matters is probable and therefore have not recorded an accrual for litigation or other contingencies related to existing legal proceedings.

ITEM 1A. Risk Factors

In addition to the other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating us and our business because such factors may significantly impact our business, operating results, and financial condition. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended, nor should be attached, to the order in which the risk factors appear.

The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions

The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. The industry environment has moved toward being more characterized by variability across segments and customers accentuated by consolidation within the industry. Variability in our customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results. The variability in our customers’ investments during any particular period is dependent on several factors, including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending and other resources allocated to operating activities.

During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems, and procedures for training and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or declining demand, our gross margins and earnings may be negatively impacted.

We continuously reassess our strategic resource allocation choices in response to the changing business environment. If we do not adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we may expand our capacity too rapidly and/or beyond what is appropriate for the actual demand environment, resulting in excess fixed costs.

Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively.

35

Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial Condition

Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor capital equipment market may experience rapid changes in demand driven both by changes in the market generally and the plans and requirements of particular customers. The economic, political, and business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically impacted customer demand for our products and normal commercial relationships with our customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and services. As a result, changing business or economic conditions can cause material adverse changes to our results of operations and financial condition, including but not limited to: 

• a decline in demand for our products or services;

• an increase in reserves on accounts receivable due to our customers’ inability to pay us;

• an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such inventory;

• valuation allowances on deferred tax assets;

• restructuring charges;

• asset impairments including the potential impairment of goodwill and other intangible assets;

• a decline in the value of our investments;

• exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that do not come to fruition;

• a decline in the value of certain facilities we lease to less than our residual value guarantee with the lessor; and

• challenges maintaining reliable and uninterrupted sources of supply.

Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, operating results, and earnings. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our profitability and other financial results.

Our Quarterly Revenues and Operating Results Are Variable

Our revenues and operating results may fluctuate significantly from quarter to quarter due to a number of factors, not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. Because our operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of gross profit from a small number of transactions can unfavorably affect operating results in a particular quarter. Factors that may cause our financial results to fluctuate unpredictably include but are not limited to:

• economic conditions in the electronics and semiconductor industries in general and specifically the semiconductor equipment industry;

• the size and timing of orders from customers;

• consolidation of the customer base, which may result in the investment decisions of one customer or market having a significant effect on demand for our products or services;

• procurement shortages;

• the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our expectations;

• manufacturing difficulties;

• customer cancellations or delays in shipments, installations, and/or customer acceptances;

• the extent that customers continue to purchase and use our products and services in their business;

• our customers’ reuse of existing and installed products, to the extent that such reuse decreases their need to purchase new products or services;

• changes in average selling prices, customer mix, and product mix;

• our ability to develop, introduce, and market new, enhanced, and competitive products in a timely manner;

• our competitors’ introduction of new products;

• legal or technical challenges to our products and technologies;

36

• transportation, communication, demand, information technology, or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, and natural or man-made disasters;

• legal, tax, accounting, or regulatory changes (including but not limited to change in import/export regulations) or changes in the interpretation or enforcement of existing requirements;

• changes in our estimated effective tax rate;

• foreign currency exchange rate fluctuations; and

• the dilutive impact of our Convertible Notes (as defined below) and related warrants on our earnings per share.

We May Incur Impairments to Goodwill or Long-Lived Assets

We review our long-lived assets, including goodwill and other intangible assets, for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Negative industry or economic trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business, slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets. If, in any period, our stock price decreases to the point where our fair value, as determined by our market capitalization, is less than the book value of our assets, this could also indicate a potential impairment, and we may be required to record an impairment charge in that period, which could adversely affect our result of operations.

Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment to goodwill in one or more of our business units, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.

Our Leverage and Debt Service Obligations and Potential Note Conversion or Related Hedging Activities May Adversely Affect Our Financial Condition, Results of Operations, and Earnings per Share

We have $2.6 billion in aggregate principal amount of senior unsecured notes and convertible note instruments outstanding. Additionally, we have $1.25 billion available to us in revolving credit arrangements, with an option for us to request an increase in the facility of up to an additional $600 million, for a potential total commitment of $1.85 billion. We may, in the future, decide to borrow amounts under the revolving credit agreement, or to enter into additional debt arrangements.

In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of nonperformance by the counterparties to our derivative instruments.

Our indebtedness could have adverse consequences, including:

• risk associated with any inability to satisfy our obligations;

• a portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for operations, working capital, capital expenditures, expansion, acquisitions, or general corporate or other purposes; and

• impairing our ability to obtain additional financing in the future.

Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows, particularly in the United States, to enable us to meet our expenses and service our debt. As a result, we may need to enter into new financing arrangements to obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default on such debt, and this default could cause us to be in default on our other outstanding indebtedness.

Conversion of our Convertible Notes and the exercise of the related warrants may cause dilution to our stockholders and to our earnings per share. The number of shares of our Common Stock into which the Convertible Notes are convertible and for which related warrants are exercisable for may be adjusted from time to time, including increases in such rates as a result of dividends that we pay to our stockholders. Upon conversion of any Convertible Notes, we will deliver cash in the amount of the principal amount of the Convertible Notes and, with respect to any excess conversion value greater than the principal amount of the Convertible Notes, shares of our Common Stock, which would result in dilution to our stockholders. This dilution may not be completely mitigated by the hedging transactions we entered into in connection with the sale of certain Convertible Notes or

37

through share repurchases. Prior to the maturity of the Convertible Notes, if the price of our Common Stock exceeds the conversion price, U.S. generally accepted accounting principles require that we report an increase in diluted share count, which would result in lower reported earnings per share. The price of our Common Stock could also be affected by sales of our Common Stock by investors who view the Convertible Notes as a more attractive means of equity participation in our company and also by hedging activity that may develop involving our Common Stock by holders of the Convertible Notes.

Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business

We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be beneficial to us, or obtain additional financing because our debt agreements contain, and any of our other future similar agreements may contain, covenant restrictions that limit our ability to, among other things:

• incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;

• create liens;

• enter into transactions with our affiliates;

• sell certain assets; and

• merge or consolidate with any person.

Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Senior Notes, the Convertible Notes, or our other debt, which could permit the holders to accelerate such debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.

We Have a Limited Number of Key Customers

Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. As a result, the actions of even one customer may subject us to variability in those areas that is difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us; compliance with specific environmental, social, and corporate governance standards; and limitations on our ability to share jointly developed technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.

We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our Success. Consequently, We Are Subject to Risks Associated with Rapid Technological Change

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products or existing products have reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture products successfully, or products that we introduce may fail in the marketplace. For more than 25 years, the primary driver of technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate more complex changes in multiple technologies in an effort to continue technology development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on developing the technology changes that are ultimately successful in supporting our customer requirements. Our failure to develop and offer the correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share, unanticipated costs, and inventory obsolescence, which would adversely affect our financial results.

In order to develop new products and processes and enhance existing products and processes, we expect to continue to make significant investments in R&D, to investigate the acquisition of new products and technologies, to invest in or acquire such business or technologies, and to pursue joint development relationships with customers, suppliers, or other members of the industry. Our investments and acquisitions may not be as successful as we may expect, particularly as we seek to invest or acquire product lines and technologies that are new to us. We may find that acquisitions are not available to us, for regulatory or other reasons, and that we must therefore limit ourselves to collaboration and joint venture development activities, which do not have the same benefits as acquisitions. Pursuing development through collaboration and/or joint development activities rather than through an acquisition poses substantial challenges for management, including those related to aligning business

38

objectives, sharing confidential information and intellectual property, sharing value with third parties, and realizing synergies that might have been available in an acquisition but are not available through a joint development project. We must manage product transitions and joint development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and certain jointly developed technologies may be subject to restrictions on our ability to share that technology with other customers, which could limit our market for products incorporating those technologies. Future technologies, processes, or product developments may render our current product offerings obsolete, leaving us with non-competitive products, obsolete inventory, or both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next-generation devices. This shift may result in a reduction in the size of our addressable markets or could increase the relative size of markets in which we either do not compete or have relatively low market share.

We Are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification

We derive a substantial percentage of our revenues from a limited number of products. Our products are priced up to approximately $10 million per system. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:

• a decline in demand for even a limited number of our products,

• a failure to achieve continued market acceptance of our key products,

• export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key customers or customers within certain markets,

• an improved version of products being offered by a competitor in the markets in which we participate,

• increased pressure from competitors that offer broader product lines,

• technological changes that we are unable to address with our products, or

• a failure to release new or enhanced versions of our products on a timely basis.

In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their business than our competitors that offer additional products and/or product capabilities. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us to additional risks associated with technology changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger impact on our business than it would on the business of our less concentrated competitors.

Strategic Alliances and Customer Consolidation May Have Negative Effects on Our Business

Increasingly, semiconductor manufacturing companies are entering into strategic alliances or consolidating with one another to expedite the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that use a specific set of manufacturing equipment, while the outcomes of consolidation can lead to an overall reduction in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include our customers re-evaluating their future supplier relationships to consider our competitors’ products and/or gaining additional influence over the pricing of products and the control of intellectual property.

Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even if they select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights, that increase our costs or require us to take on greater risk. These actions could adversely impact our market share and financial results.

We Depend on a Limited Number of Key Suppliers and Outsource Providers, and We Run the Risk That They Might Not Perform as We Expect

Outsource providers and component suppliers have played and will continue to play a key role in our manufacturing operations, field installation and support, and many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties, become subject to exclusivity arrangements that preclude further business with us, or be

39

unable to meet our requirements or expectation due to their independent business decisions or force majeure events that could interrupt or impair their continued ability to perform as we expect.

Although we attempt to select reputable providers and suppliers and we attempt to secure their performance on terms documented in written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. There is therefore a risk that a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship products, and generate revenues, which could adversely affect our operating results and damage our customer relationships.

We Face Risks Related to the Disruption of Our Primary Manufacturing Facilities

Our manufacturing facilities are concentrated in just a few locations. These locations are subject to disruption for a variety of reasons, such as natural or man-made disasters, terrorist activities, disruptions of our information technology resources, and utility interruptions. Such disruptions may cause delays in shipping our products, which could result in the loss of business or customer trust, adversely affecting our business and operating results.

Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase That Competitor’s Equipment, Making It More Difficult for Us to Sell Our Equipment to That Customer

Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially for customers that are more focused on tool reuse. Accordingly, we expect it to be more difficult to sell our products to a given customer if that customer initially selects a competitor’s equipment for the same product line application.

We Face a Challenging and Complex Competitive Environment

We face significant competition from multiple competitors, and with increased consolidation efforts in our industry, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire businesses and products that are competitive to ours and may introduce new products and product capabilities that may affect our ability to sell our existing products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.

We believe that to remain competitive we must devote significant financial resources to offer products that meet our customers’ needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Certain of our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to offer customers a more comprehensive array of products and/or product capabilities and to therefore achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. We also face competition from our own customers, who in some instances have established affiliated entities that manufacture equipment similar to ours. In addition, we face competition from companies that exist in a more favorable legal or regulatory environment than we do, allowing the freedom of action in ways that we may be unable to match. In many cases speed to solution is necessary for customer satisfaction and our competitors may be better positioned to achieve these objectives. For these reasons, we may fail to continue to compete successfully worldwide.

In addition, our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be unable to continue to

40

compete successfully in our markets, which could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.

Our Future Success Depends Heavily on International Sales and the Management of Global Operations

Non-U.S. sales, as reflected in Part 1 Item 1. Business, accounted for approximately 94%, 92%, and 92% of total revenue in the three months ended September 24, 2017 and fiscal years 2017, and 2016, respectively. We expect that international sales will continue to account for a substantial majority of our total revenue in future years.

We are subject to various challenges related to international sales and the management of global operations including but not limited to:

• trade balance issues;

• tariffs and other barriers;

• global or national economic and political conditions;

• changes in currency controls;

• differences in the enforcement of intellectual property and contract rights in varying jurisdictions;

• our ability to respond to customer and foreign government demands for locally sourced systems, spare parts, and services and develop the necessary relationships with local suppliers;

• compliance with U.S. and international laws and regulations affecting foreign operations, including U.S. and international trade restrictions and sanctions, anti-bribery, anti-corruption, environmental, tax, and labor laws;

• fluctuations in interest and foreign currency exchange rates;

• our ability to repatriate cash in a tax-efficient manner;

• the need for technical support resources in different locations; and

• our ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the successful operation of our business.

Certain international sales depend on our ability to obtain export licenses from the U.S. government. Our failure or inability to obtain such licenses would substantially limit our markets and severely restrict our revenues. Many of the challenges noted above are applicable in China, which is a fast developing market for the semiconductor equipment industry and therefore an area of potential significant growth for our business. As the business volume between China and the rest of the world grows, there is inherent risk, based on the complex relationships among China, Japan, Korea, Taiwan, and the United States, that political and diplomatic influences might lead to trade disruptions. This would adversely affect our business with China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region. A significant trade disruption in these areas could have a materially adverse impact on our future revenue and profits. In addition, there are risks that the Chinese government may, among other things, insist on the use of local suppliers; compel companies that do business in China to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our revenues and margins.

We are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and expenses denominated in euro and Korean won. Currently, we hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and expenses dominated in euro and Korean won. In addition, we enter into foreign currency hedge contracts to minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency monetary assets and liabilities, primarily third-party accounts receivables, accounts payables, and intercompany receivables and payables. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us either over or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues, expenses, monetary assets, and liabilities, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated monetary assets and liabilities (other than those currency exposures previously discussed), and currently we do not enter into foreign currency hedge contracts against these exposures. Therefore, we are subject to potential unfavorable foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany transactions) in these currencies.

The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases, payment of dividends, or the repayment of our notes, can usually only be made with onshore cash balances. Since

41

the majority of our cash is generated outside of the United States, this may impact certain business decisions and adversely affect business outcomes.

Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success

Our ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees with the appropriate skills, experiences and competencies. This is an ongoing challenge due to intense competition for top talent, fluctuations in industry or business economic conditions, as well as increasing geographic expansion that may require cycles of hiring activity and workforce reductions. Our success in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs, global economic or political and industry conditions, our organizational structure, global competition for talent and the availability of qualified employees, the availability of career development opportunities, the ability to obtain necessary authorizations for workers to provide services outside their home countries, and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall compensation and benefit programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. If we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities and our operating results may be materially and adversely affected.

We Rely upon Certain Critical Information Systems for the Operation of Our Business That Are Susceptible to Cybersecurity and Other Threats or Incidents

We maintain and rely upon certain critical information systems for the effective operation of our business. These information systems include but are not limited to, telecommunications, the Internet, our corporate intranet, various computer hardware and software applications, network communications, and email. These information systems may be owned and maintained by us, our outsourced providers, or third parties such as vendors, contractors, and Cloud providers. Many of these information systems and outsourced service providers, including certain hosted software applications that we use for storage of confidential data and data processing (e.g., company-related, whether intellectual property or not; customer-related; supplier-related; and/or employee-related), employ Cloud technology for such storage and data processing (which refers to an information technology hosting and delivery system in which data is not stored or processed within the user’s physical infrastructure but instead is delivered to and consumed by the user as an Internet-based service). All of these information systems are subject to disruption, breach or failure from sources including but not limited to attacks, degradation, and failures resulting from potential sources, including viruses, malware, denial of service, destructive or inadequate code, power failures, and physical damage to computers, hard drives, communication lines, and networking equipment. Confidential and/or sensitive information stored on these information systems or transmitted to or from Cloud storage could be intentionally or unintentionally compromised, lost, and/or stolen. While we have implemented ISO 27001 compliant security procedures and virus protection software, intrusion prevention systems, access control, and emergency recovery processes to mitigate the outlined risks with respect to information systems that are under our control, they cannot be guaranteed to be fail-safe and may be breached. Our inability to use or access these information systems at critical points in time, or unauthorized releases of proprietary or confidential information, could unfavorably impact the timely and efficient operation of our business, including our results of operations, and our reputation.

We have experienced cyber attacks. Although past attacks have not resulted in a material adverse effect, we may incur material losses related to cyber attacks in the future. The insurance we carry may not fully compensate us for the effects of potential losses arising from a cyber-related incident. Cyber-related incidents could result in:

• disruptions to our operations;

• misappropriation or theft of Company, customer, supplier, or other’s assets or resources, including intellectual property and confidential information, and costs associated therewith;

• litigation with, or claims of damages arising from, our employees, customers, suppliers, or other third parties which whom we collaborate; or

• adverse impact to our results of operations, as a result of associated remediation costs such as those related to responding to potential regulatory inquiries, to rebuild the effected information systems, and those associated with improving our security and internal control environment.

Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional Tax Liabilities

As a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. We are subject to income taxes in the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, by material audit assessments, or changes in or expirations of agreements with tax authorities. These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United

42

States, is dependent on our ability to generate future taxable income in the United States. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability.

A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results

We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, and disposal of toxic, volatile, or otherwise hazardous chemicals. Failure to comply with present or future environmental regulations could result in fines being imposed on us, require us to suspend production, and/or cease operations, or cause our customers to not accept our products. These regulations could require us to alter our current operations, acquire significant additional equipment, incur substantial other expenses to comply with environmental regulations, or take other actions. Any failure to comply with regulations governing the use, handling, sale, transport, or disposal of hazardous substances could subject us to future liabilities that may adversely affect our operating results, financial condition, and ability to operate our business.

If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance

An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, or enhance our technological capabilities. As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs, reduced or lost opportunities, and diversion of management’s attention. Managing an acquired business, disposing of product technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management’s attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or technologies, or reduction in personnel or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, and/or cash flows.

In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, results of operations, cash flows, and/or the price of our Common Stock.

The Market for Our Common Stock Is Volatile, Which May Affect Our Ability to Raise Capital or Make Acquisitions or May Subject Our Business to Additional Costs

The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not within our control or influence. These factors include but are not limited to the following:

• general market, semiconductor, or semiconductor equipment industry conditions;

• economic or political events, trends, and unexpected developments occurring nationally, globally, or in any of our key sales regions;

• variations in our quarterly operating results and financial condition, including our liquidity;

• variations in our revenues, earnings, or other business and financial metrics from forecasts by us or securities analysts or from those experienced by other companies in our industry;

• announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;

• government regulations;

• developments in, or claims relating to, patent or other proprietary rights;

• technological innovations and the introduction of new products by us or our competitors;

• commercial success or failure of our new and existing products;

• disruptions of relationships with key customers or suppliers; or

• dilutive impacts of our Convertible Notes and related warrants.

43

In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of their stock, many companies became the object of securities class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial performance and the price for our Common Stock.

Intellectual Property, Indemnity, and Other Claims Against Us Can Be Costly and We Could Lose Significant Rights That Are Necessary to Our Continued Business and Profitability

Third parties may assert infringement, unfair competition, product liability, breach of contract, or other claims against us. From time to time, other persons send us notices alleging that our products infringe their patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges relating to intellectual property or other issues. We also face risks of claims arising from commercial and other relationships. In addition, our bylaws and other indemnity obligations provide that we will indemnify officers and members of our Board of Directors against losses that they may incur in legal proceedings resulting from their service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially adversely affect our business and financial results, and we may be subject to substantial damage awards and penalties. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles.

We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business

Our success depends in part on our proprietary technology and our ability to protect key components of that technology through patents, copyrights, and trade secret protection. Protecting our key proprietary technology helps us to achieve our goals of developing technological expertise and new products and systems that give us a competitive advantage; increasing market penetration and growth of our installed base; and providing comprehensive support and service to our customers. As part of our strategy to protect our technology, we currently hold a number of U.S. and foreign patents and pending patent applications, and we keep certain information, processes, and techniques as trade secrets. However, other parties may challenge or attempt to invalidate or circumvent any patents the U.S. or foreign governments issue to us; these governments may fail to issue patents for pending applications; or we may lose trade secret protection over valuable information due to the intentional or unintentional actions or omissions of third parties, of ours, or even of our own employees. Additionally, intellectual property litigation can be expensive and time-consuming and even when patents are issued or trade secret processes are followed, the legal systems in certain of the countries in which we do business do not enforce patents and other intellectual property rights as rigorously as the United States. The rights granted or anticipated under any of our patents, pending patent applications, or trade secrets may be narrower than we expect or, in fact, provide no competitive advantages. Moreover, because we determine the jurisdictions in which to file patents at the time of filing, we may not have adequate protection in the future based on such previous decisions. Any of these circumstances could have a material adverse impact on our business.

We Are Exposed to Various Risks from Our Regulatory Environment

We are subject to various risks related to (1) new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative bodies and/or regulatory agencies in the countries that we operate; (2) disagreements or disputes between national or regional regulatory agencies related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including those related to financial and other disclosures, corporate governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, conflict minerals or other social responsibility legislation, immigration or travel regulations, and antitrust regulations, among others. Each of these laws, rules, and regulations imposes costs on our business, including financial costs and potential diversion of our management’s attention associated with compliance, and may present risks to our business, including potential fines, restrictions on our actions, and reputational damage if we are unable to fully comply.

44

To maintain high standards of corporate governance and public disclosure, we intend to invest all reasonably necessary resources to comply with all evolving standards. Changes in or ambiguous interpretations of laws, regulations, and standards may create uncertainty regarding compliance matters. Efforts to comply with new and changing regulations have resulted in, and are likely to continue to result in, increased selling, general, and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with the laws and regulations, our business, financial condition, and/or results of operations could be adversely affected.

There Can Be No Assurance That We Will Continue to Declare Cash Dividends or Repurchase Our Shares at All or in Any Particular Amounts

Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and, in the case of dividends, periodic determinations by our Board of Directors that cash dividends are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends by us. Future dividends and share repurchases may also be affected by, among other factors, our views on potential future capital requirements for investments in acquisitions and the funding of our research and development; legal risks; changes in federal and state income tax laws or corporate laws; contractual restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments could have a negative effect on the price of our Common Stock.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Company Shares

In November 2016, the Board of Directors authorized us to repurchase up to $1.0 billion of Common Stock, which included the remaining value available under our prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases will be funded using our on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.

Share repurchases, including those under the repurchase program, were as follows:

	Total Number of Shares Repurchased (1)	Average Price Paid Per Share (2)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Amount Available Under Repurchase Program
	(in thousands, except share and per share data)
Amount available at June 25, 2017					$	282,141
June 26, 2017 - July 23, 2017	989	$	152.81	986	250,996
July 24, 2017 - August 20, 2017	484	$	155.04	480	176,516
August 21, 2017 - September 24, 2017	317	$	167.15	313	124,203
Quarter ended September 24, 2017	1,790	$	158.40	1,779	$	124,203

(1) During the three months ended September 24, 2017, the Company acquired 11 thousand shares at a total cost of $1.8 million, which the Company withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

(2) Average price paid per share excludes effect accelerated share repurchases; see additional disclosure below regarding our accelerated share repurchase activity during the fiscal year.

On April 19, 2017, the Company entered into two separate accelerated share repurchase agreements (collectively, the “ASR”) with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 2,570,000 shares, which represented 70% of the prepayment amount divided by the Company’s closing stock price on April 19, 2017. The total number of shares to be received under the ASR is based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Following the fiscal year end, the counterparties designated June 30, 2017 as the termination date, at which time the Company settled the ASR.

45

Approximately 780,000 shares were received at final settlement, which resulted in a weighted-average share price of approximately $149.16 for the transaction period.

ITEM 3. Defaults Upon Senior Securities

None.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

ITEM 6. Exhibits

See the Exhibit Index following the signature page to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this report, which Exhibit Index is incorporated herein by reference.

46

LAM RESEARCH CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	October 23, 2017	LAM RESEARCH CORPORATION (Registrant)
		/s/ Douglas R. Bettinger
		Douglas R. Bettinger
		Executive Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

47

EXHIBIT INDEX

Exhibit Number	Description
10.1 (1)	Amendment No. 2 to Amended and Restated Credit Agreement, dated October 13, 2017, among Lam Research Corporation, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.
31.1	Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2	Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer)
32.1	Section 1350 Certification (Principal Executive Officer)
32.2	Section 1350 Certification (Principal Financial Officer)
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
(1)	Incorporated by reference to Registrant’s Current Report on Form 8-K filed on October 17, 2017 (SEC File No. 000-12933)

48

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

I, Martin B. Anstice, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 23, 2017

/s/ Martin B. Anstice

Martin B. Anstice

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

I, Douglas R. Bettinger, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

October 23, 2017

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President, Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

EX-32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending September 24, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin B. Anstice, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 23, 2017

/s/ Martin B. Anstice

Martin B. Anstice

President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

SECTION 1350 CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending September 24, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas R. Bettinger, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

October 23, 2017

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President, Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Document and Entity Information - shares	3 Months Ended
	Sep. 24, 2017	Oct. 19, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 24, 2017
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Trading Symbol	LRCX
Entity Registrant Name	LAM RESEARCH CORP
Entity Central Index Key	0000707549
Current Fiscal Year End Date	--06-24
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		161,946,248

XML

Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Income Statement [Abstract]
Revenue	$ 2,478,140	$ 1,632,419
Cost of goods sold	1,328,797	916,222
Gross margin	1,149,343	716,197
Research and development	275,078	235,240
Selling, general, and administrative	181,043	165,010
Total operating expenses	456,121	400,250
Operating income	693,222	315,947
Other expense, net	(5,502)	(23,154)
Income before income taxes	687,720	292,793
Income tax expense	(97,030)	(28,958)
Net income	$ 590,690	$ 263,835
Net income per share:
Basic (in dollars per share)	$ 3.64	$ 1.64
Diluted (in dollars per share)	$ 3.21	$ 1.47
Number of shares used in per share calculations:
Basic (in shares)	162,141	160,607
Diluted (in shares)	183,880	180,017
Cash dividend declared per common share (in dollars per share)	$ 0.45	$ 0.3

XML

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 590,690	$ 263,835
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	7,869	4,501
Cash flow hedges:
Net unrealized gains (losses) during the period	3,062	(2,421)
Net losses reclassified into earnings	2,188	11,950
Net change	5,250	9,529
Available-for-sale investments:
Net unrealized losses during the period	(1,727)	(2,723)
Net (gains) losses reclassified into earnings	(123)	903
Net change	(1,850)	(1,820)
Defined benefit plans, net change in unrealized component	(2,356)	123
Other comprehensive income, net of tax	8,913	12,333
Comprehensive income	$ 599,603	$ 276,168

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017	[1]
ASSETS
Cash and cash equivalents	$ 2,406,462	$ 2,377,534
Investments	3,775,925	3,663,628
Accounts receivable, less allowance for doubtful accounts of $5,271 as of September 24, 2017, and $5,103 as of June 25, 2017	1,530,762	1,673,398
Inventories	1,328,297	1,232,916
Prepaid expenses and other current assets	187,334	195,022
Total current assets	9,228,780	9,142,498
Property and equipment, net	745,600	685,595
Restricted cash and investments	256,045	256,205
Goodwill	1,484,030	1,385,673
Intangible assets, net	420,359	410,995
Other assets	263,812	241,799
Total assets	12,398,626	12,122,765
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	471,805	464,643
Accrued expenses and other current liabilities	1,078,998	969,361
Deferred profit	597,921	607,672
Current portion of convertible notes and capital leases	639,907	908,439
Total current liabilities	2,788,631	2,950,115
Senior notes, convertible notes, and capital leases, less current portion	1,793,477	1,784,974
Income taxes payable	129,611	120,178
Other long-term liabilities	278,733	280,186
Total liabilities	4,990,452	5,135,453
Commitments and contingencies
Temporary equity, convertible notes	136,996	169,861
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding	0	0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares; issued and outstanding, 162,144 shares at September 24, 2017, and 161,723 shares at June 25, 2017	162	162
Additional paid-in capital	5,891,549	5,845,485
Treasury stock, at cost; 107,360 shares at September 24, 2017, and 105,569 shares at June 25, 2017	(5,375,920)	(5,216,187)
Accumulated other comprehensive loss	(52,787)	(61,700)
Retained earnings	6,808,174	6,249,691
Total stockholders’ equity	7,271,178	6,817,451
Total liabilities and stockholders’ equity	$ 12,398,626	$ 12,122,765

[1] Derived from audited financial statements

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 5,271	$ 5,103
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	162,144,000	161,723,000
Common stock, shares outstanding	162,144,000	161,723,000
Treasury stock, shares	107,360,000	105,569,000

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017		Sep. 25, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 590,690		$ 263,835
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	79,142		74,562
Deferred income taxes	43,204		7,633
Equity-based compensation expense	41,783		38,595
Amortization of note discounts and issuance costs	4,588		6,830
Other, net	6,569		16,807
Changes in operating assets and liabilities	92,330		64,962
Net cash provided by operating activities	858,306		473,224
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(60,064)		(41,979)
Business acquisition, net of cash acquired	(115,613)		0
Purchases of available-for-sale securities	(1,425,407)		(38,149)
Sales and maturities of available-for-sale securities	1,307,633		469,899
Transfers of restricted cash and investments	160		(5,219)
Other, net	(10,600)		(7,800)
Net cash (used for) provided by investing activities	(303,891)		376,752
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations and payments for debt issuance costs	(301,727)		(371)
Treasury stock purchases	(155,385)		(1,854)
Dividends paid	(72,738)		(48,052)
Reissuance of treasury stock related to employee stock purchase plan	0		19,320
Proceeds from issuance of common stock	1,042		1,459
Other, net	4		(10)
Net cash used for financing activities	(528,804)		(29,508)
Effect of exchange rate changes on cash and cash equivalents	3,317		1,911
Net increase in cash and cash equivalents	28,928		822,379
Cash and cash equivalents at beginning of period	2,377,534	[1]	5,039,322
Cash and cash equivalents at end of period	2,406,462		5,861,701
Schedule of non-cash transactions:
Accrued payables for stock repurchases	4,350		0
Accrued payables for capital expenditures	34,531		11,631
Dividends payable	73,127		48,397
Transfers of inventory to property and equipment, net	$ 11,852		$ 13,419

[1] Derived from audited financial statements

XML

BASIS OF PRESENTATION

3 Months Ended

Sep. 24, 2017

Accounting Policies [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 25, 2017, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 25, 2017 (the “2017 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at http://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 24, 2018 and includes 52 weeks. The quarters ended September 24, 2017 (the “September 2017 quarter”) and September 25, 2016 (the “September 2016 quarter”) included 13 weeks.

XML

RECENT ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Sep. 24, 2017

Accounting Changes and Error Corrections [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted

In November 2015, the Financial Accounting Standards Board (“FASB”) issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The Company adopted this standard prospectively in the first quarter of fiscal year 2018. The implementation resulted in a net reduction of prepaid expense and other current assets of $49.7 million, accrued expense and other current liabilities of $5.3 million, and other long-term liabilities of $39.4 million; and an increase in other assets of $5.0 million in the Company’s Condensed Consolidated Balance Sheet, and had no impact on cash provided by or used in operations for any period presented.

In March 2016, the FASB released ASU 2016-9, “Compensation – Stock Compensation.” Key changes in the amendment include:

• entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating additional paid in capital (“APIC”) pools;

• entities will no longer be required to delay recognition of excess tax benefits until they are realized;

• entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows;

• entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur;

• entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability; and

• the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows.

The Company adopted this standard in the first quarter of fiscal year 2018. As a result of the adoption, the Company recorded a $40.9 million cumulative-effect adjustment to retained earnings for the recognition of previously unrecognized excess tax benefits for all years prior to the adoption. As required by the standard update, the amendment was applied prospectively to recognize excess tax benefits or deficiencies in the income statement in the period of occurrence. Additionally, the Company has elected to apply the change in cash flow classification on a prospective basis. The Company has elected to continue to estimate the number of forfeitures expected to occur to determine the amount of compensation cost to be recognized each period. The Company has elected to adopt the effects of the standard update with regard to the income tax withholdings obligations on a prospective basis, such withholdings in the period ended September 24, 2017 were not material.

Updates Not Yet Effective

In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers,” to supersede nearly all existing revenue recognition guidance under GAAP. The FASB issued subsequent amendments to the initial guidance in August 2015, March 2016, April 2016, May 2016 and December 2016 within ASU 2015-14, ASU 2016-08, ASU 2016-10, ASU 2016-12 and ASU 2016-20, respectively. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each separate performance obligation.

The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (1) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (2) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method. The Company is continuing its evaluation of the impact that the new standard will have on its Condensed Consolidated Financial Statements and disclosures, business processes, systems, and controls. While the Company’s evaluation of the impact of the standard on its financial statements with respect to its spare parts and service revenue has not been completed, the Company believes that the timing of revenue recognition for certain of its systems will generally be earlier than under existing revenue recognition guidance. The Company continues to evaluate the impact to its revenues related to its pending adoption of these standards and its preliminary assessments are subject to change.

In January 2016, the FASB released ASU 2016-1, “Financial Instruments – Overall – Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity’s other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact on its Condensed Consolidated Financial Statements.

In January 2016, the FASB released ASU 2016-2, “Leases.” The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In June 2016, the FASB released ASU 2016-13, “Financial Instruments – Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2016, the FASB released ASU 2016-15, “Statement of Cash Flows – Classification of Certain Cash Receipts and Cash Payments.” The amendment provides and clarifies guidance on the classification of certain cash receipts and cash payments in the statement of cash flows to eliminate diversity in practice. The Company is required to adopt the standard update in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In October 2016, the FASB released ASU 2016-16, “Income Tax – Intra-Entity Transfers of Assets Other than Inventory.” This standard update improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Early adoption is permitted. The Company is required to adopt the standard in the first quarter of fiscal year 2019. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In November 2016, the FASB released ASU 2016-18, “Statement of Cash Flows – Restricted Cash.” This standard update requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company is required to adopt this standard in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2017, the FASB released ASU 2017-12, “Targeted Improvements to Accounting for Hedging Activities.” The new guidance is intended to: (1) more closely align hedge accounting with an entity’s risk management strategies, (2) simplify the application of hedge accounting by eliminating the requirement to separately measure and report hedge ineffectiveness, and (3) increase transparency around the scope and results of hedging programs. The Company is required to adopt the standard in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

XML

EQUITY-BASED COMPENSATION PLANS

3 Months Ended

Sep. 24, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

EQUITY-BASED COMPENSATION PLANS

EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s options, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands)
Equity-based compensation expense	$	41,783	$	38,595
Income tax benefit recognized related to equity-based compensation expense	$	13,387	$	10,905

The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis. In the first quarter of fiscal year 2018, the Company adopted ASU 2016-9, “Compensation – Stock Compensation,” as discussed further in Note 2.

XML

OTHER EXPENSE, NET

3 Months Ended

Sep. 24, 2017

Other Income and Expenses [Abstract]

OTHER EXPENSE, NET

OTHER EXPENSE, NET

The significant components of other expense, net, are as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Interest income	$	20,209		$	12,763
Interest expense	(23,905		)	(41,429		)
Gains on deferred compensation plan related assets, net	3,453			6,172
Foreign exchange (losses) gains, net	(3,000		)	1,219
Other, net	(2,259		)	(1,879		)
	$	(5,502	)	$	(23,154	)

Interest income in the three months ended September 24, 2017, increased compared to the three months ended September 25, 2016, due to longer portfolio duration and higher yield. Interest expense decreased in the September 2017 quarter, compared to the September 2016 quarter, due to the termination of the Term Loan Agreement and mandatory redemption of the Senior Notes due 2023 and 2026 during the December 2016 quarter.

XML

INCOME TAX EXPENSE

3 Months Ended

Sep. 24, 2017

Income Tax Disclosure [Abstract]

INCOME TAX EXPENSE

INCOME TAX EXPENSE

The Company recorded an income tax expense of $97.0 million for the three months ended September 24, 2017, which yielded an effective tax rate of approximately 14.1%.

The difference between the U.S. federal statutory tax rate of 35% and the Company’s effective tax rate for the three months months ended September 24, 2017, is primarily due to income in lower tax jurisdictions.

The Company is in various stages of examination in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its unrecognized tax benefits as a result of tax examinations or lapses of statute of limitation. The estimated reduction in unrecognized tax benefits may range from $15 million to $50 million.

XML

NET INCOME PER SHARE

3 Months Ended

Sep. 24, 2017

Earnings Per Share [Abstract]

NET INCOME PER SHARE

NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, convertible notes, and warrants. Dilutive shares outstanding include the effect of the convertible notes. Refer to Note 11 for additional information regarding the Company’s convertible notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. 

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands, except per share data)
Numerator:
Net income	$	590,690	$	263,835
Denominator:
Basic average shares outstanding	162,141		160,607
Effect of potential dilutive securities:
Employee stock plans	2,514		2,142
Convertible notes	15,151		15,220
Warrants	4,074		2,048
Diluted average shares outstanding	183,880		180,017
Net income per share - basic	$	3.64	$	1.64
Net income per share - diluted	$	3.21	$	1.47

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:

	Three Months Ended
	September 24, 2017	September 25, 2016
	(in thousands)
Number of options and RSUs excluded	7	196

Diluted shares outstanding do not include any effect resulting from note hedges associated with the Company’s 2018 Notes as their impact would have been anti-dilutive.

XML

FINANCIAL INSTRUMENTS

3 Months Ended

Sep. 24, 2017

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 11 to the Condensed Consolidated Financial Statements for additional information regarding the fair value of the Company’s Senior Notes and Convertible Notes.

The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of September 24, 2017, and June 25, 2017:

	September 24, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	543,990	$	—	$	—		$	543,990	$	537,972	$	—	$	6,018	$	—
Level 1:
Time deposit	693,205		—		—			693,205		443,178		—		250,027		—
Money market funds	1,395,032		—		—			1,395,032		1,395,032		—		—		—
U.S. Treasury and agencies	821,441		265		(2,569		)	819,137		15,648		803,489		—		—
Mutual funds	53,131		3,125		(70		)	56,186		—		—		—		56,186
Level 1 Total	2,962,809		3,390		(2,639		)	2,963,560		1,853,858		803,489		250,027		56,186
Level 2:
Municipal notes and bonds	165,029		322		(21		)	165,330		—		165,330		—		—
U.S. Treasury and agencies	12,798		—		(102		)	12,696		—		12,696		—		—
Government-sponsored enterprises	55,845		—		(322		)	55,523		—		55,523		—		—
Foreign government bonds	67,040		90		(128		)	67,002		—		67,002		—		—
Corporate notes and bonds	2,532,374		4,020		(2,376		)	2,534,018		14,632		2,519,386		—		—
Mortgage backed securities — residential	46,614		63		(116		)	46,561		—		46,561		—		—
Mortgage backed securities — commercial	106,173		40		(275		)	105,938		—		105,938		—		—
Level 2 Total	2,985,873		4,535		(3,340		)	2,987,068		14,632		2,972,436		—		—
Total	$	6,492,672	$	7,925	$	(5,979	)	$	6,494,618	$	2,406,462	$	3,775,925	$	256,045	$	56,186

	June 25, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	551,308	$	—	$	—		$	551,308	$	545,130	$	—	$	6,178	$	—
Level 1:
Time deposit	640,666		—		—			640,666		390,639		—		250,027		—
Money market funds	1,423,417		—		—			1,423,417		1,423,417		—		—		—
U.S. Treasury and agencies	783,848		684		(2,111		)	782,421		8,297		774,124		—		—
Mutual funds	53,247		3,007		—			56,254		—		—		—		56,254
Level 1 Total	2,901,178		3,691		(2,111		)	2,902,758		1,822,353		774,124		250,027		56,254
Level 2:
Municipal notes and bonds	194,575		308		(7		)	194,876		—		194,876		—		—
U.S. Treasury and agencies	12,795		—		(167		)	12,628		—		12,628		—		—
Government-sponsored enterprises	24,502		—		(6		)	24,496		—		24,496		—		—
Foreign government bonds	62,917		219		(114		)	63,022		—		63,022		—		—
Corporate notes and bonds	2,433,622		4,654		(1,840		)	2,436,436		10,051		2,426,385		—		—
Mortgage backed securities — residential	102,760		87		(489		)	102,358		—		102,358		—		—
Mortgage backed securities — commercial	65,828		9		(98		)	65,739		—		65,739		—		—
Level 2 Total	2,896,999		5,277		(2,721		)	2,899,555		10,051		2,889,504		—		—
Total	$	6,349,485	$	8,968	$	(4,832	)	$	6,353,621	$	2,377,534	$	3,663,628	$	256,205	$	56,254

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The Company did not recognize any losses on investments due to other-than-temporary impairments during the three months ended September 24, 2017 or September 25, 2016. Additionally, gross realized gains/(losses) from sales of investments were approximately $0.8 million and $(1.0) million, respectively, in the three months ended September 24, 2017, and $2.6 million and $(0.2) million, respectively, in the three months ended September 25, 2016.

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions:

	September 24, 2017
	Unrealized Losses Less than 12 Months					Unrealized Losses 12 Months or Greater					Total
	Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	660,429	$	(2,671	)	$	—	$	—		$	660,429	$	(2,671	)
Municipal notes and bonds	18,653		(21		)	—		—			18,653		(21		)
Mutual funds	3,122		(70		)	—		—			3,122		(70		)
Government-sponsored enterprises	55,297		(322		)	—		—			55,297		(322		)
Foreign government bonds	33,729		(128		)	—		—			33,729		(128		)
Corporate notes and bonds	1,282,655		(2,376		)	—		—			1,282,655		(2,376		)
Mortgage backed securities — residential	30,210		(93		)	2,006		(23		)	32,216		(116		)
Mortgage backed securities — commercial	98,303		(261		)	2,634		(14		)	100,937		(275		)
	$	2,182,398	$	(5,942	)	$	4,640	$	(37	)	$	2,187,038	$	(5,979	)

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of September 24, 2017:

	Cost		Estimated Fair Value
	(in thousands)
Due in one year or less	$	2,764,552	$	2,764,415
Due after one year through five years	2,987,295		2,986,525
Due in more than five years	143,704		143,502
	$	5,895,551	$	5,894,442

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than twelve months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments (“derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.

Cash Flow Hedges

The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues and euro- denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within 12 months and no later than 24 months. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized.

In addition, the Company has entered into interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive (loss) and is amortized into income as the hedged item impacts earnings.

At inception and at each quarter-end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. Changes in the fair value of foreign exchange options due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating to both the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the three months ended September 24, 2017 or September 25, 2016 associated with ineffectiveness or forecasted transactions that failed to occur.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value associated with the forward contracts and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of September 24, 2017, the Company had gains of $6.3 millionaccumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next 12 months. Additionally, the Company had a net loss of $1.9 million accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next 7.5 years.

Fair Value Hedges

The Company has interest rate contracts whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of other expense, net in our Condensed Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized.

Balance Sheet Hedges

The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense).

As of September 24, 2017, the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs:

	Notional Value
	Derivatives Designated as Hedging Instruments:				Derivatives Not Designated as Hedging Instruments:
	(in thousands)
Foreign currency forward contracts
	Buy Contracts		Sell Contracts		Buy Contracts		Sell Contracts
Japanese yen	$	—	$	393,345	$	—	$	282,311
Euro	31,917		—		31,246		—
Korean won	13,536		—		—		84,122
Taiwan dollar	—		—		12,658		—
Swiss franc	—		—		9,375		—
Chinese renminbi	—		—		7,137
Singapore dollar	—		—		4,469		—
	$	45,453	$	393,345	$	64,885	$	366,433
Foreign currency option contracts
	Buy Put		Sell Put		Buy Put(1)		Sell Put
Japanese yen	$	36,036	$	—	$	8,929	$	8,929

(1) Contracts were entered into and designated as cash flow hedges under ASC 815 at contract inception as part of the Company’s cash flow hedge program. The contracts were subsequently de-designated; changes in fair market value subsequent to de-designation effect current earnings.

The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of September 24, 2017, and June 25, 2017 were as follows:

	September 24, 2017						June 25, 2017
	Fair Value of Derivative Instruments (Level 2)						Fair Value of Derivative Instruments (Level 2)
	Asset Derivatives			Liability Derivatives			Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
	(in thousands)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	$	9,598	Accrued expenses and other current liabilities	$	368	Prepaid expense and other assets	$	8,061	Accrued expenses and other current liabilities	$	2,916
Interest rate contracts, short-term	Prepaid expense and other assets	316								Accrued expenses and other current liabilities	2,833
Interest rate contracts, long-term				Other long-term liabilities	13,077					Other long-term liabilities	7,269
Derivatives not designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	109		Accrued expenses and other current liabilities	461		Prepaid expense and other assets	213		Accrued expenses and other current liabilities	342
Total Derivatives		$	10,023		$	13,906		$	8,274		$	13,360

Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of September 24, 2017, the potential effect of rights of offset associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by $5.1 million, resulting in a net derivative asset of $4.9 million and net derivative liability of $8.8 million. As of June 25, 2017, the potential effect of rights of offset associated with the above foreign exchange contracts would be an offset to both assets and liabilities by $5.9 million, resulting in a net derivative asset of $2.3 million and a net derivative liability of $7.4 million. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions.

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:

		Three Months Ended September 24, 2017									Three Months Ended September 25, 2016
		Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness			Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness
Derivatives Designated as Hedging Instruments	Location of  Gain (Loss) Recognized  in or  Reclassified into Income	(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income			(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Revenue	$	(9	)	$	(3,806	)	$	2,547		$	(2,913	)	$	(13,605	)	$	705
Foreign Exchange Contracts	Cost of goods sold	2,443			824			(208		)	235			173			(67		)
Foreign Exchange Contracts	Selling, general, and administrative	1,356			714			(117		)	(24		)	(9		)	(21		)
Foreign Exchange Contracts	Other expense, net	—			—			(17		)	—			—			—
Interest Rate Contracts	Other expense, net	—			(31		)	—			—			9			—
		$	3,790		$	(2,299	)	$	2,205		$	(2,702	)	$	(13,432	)	$	617

The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended
		September 24, 2017		September 25, 2016
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Income		Loss Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Other  income	$	2,672	$	(383	)

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company.

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

XML

INVENTORIES

3 Months Ended

Sep. 24, 2017

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Raw materials	$	721,352	$	625,600
Work-in-process	200,271		213,066
Finished goods	406,674		394,250
	$	1,328,297	$	1,232,916

XML

GOODWILL AND INTANGIBLE ASSETS

3 Months Ended

Sep. 24, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.5 billion and $1.4 billion as of September 24, 2017, and June 25, 2017, respectively. As of September 24, 2017, $61.1 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.

Intangible Assets

The following table provides the Company’s intangible assets:

	September 24, 2017							June 25, 2017
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
	(in thousands)
Customer relationships	$	630,257	$	(383,131	)	$	247,126	$	615,164	$	(366,439	)	$	248,725
Existing technology	669,603		(508,983		)	160,620		643,196		(487,056		)	156,140
Patents	36,553		(31,872		)	4,681		36,553		(31,238		)	5,315
Other intangible assets	43,814		(35,882		)	7,932		36,514		(35,699		)	815
Total intangible assets	$	1,380,227	$	(959,868	)	$	420,359	$	1,331,427	$	(920,432	)	$	410,995

The Company recognized $39.3 million and $38.7 million in intangible asset amortization expense during the three months ended September 24, 2017, and September 25, 2016, respectively. Refer to Note 15 - Business Combinations for additional information regarding intangible assets acquired during the three months ended September 24, 2017.

The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 24, 2017, was as follows:

Fiscal Year	Amount
	(in thousands)
2018 (remaining 9 months)	$	121,147
2019	123,429
2020	58,296
2021	55,611
2022	51,801
Thereafter	10,075
	$	420,359

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

3 Months Ended

Sep. 24, 2017

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Accrued compensation	$	510,583	$	447,363
Warranty reserves	168,337		161,981
Income and other taxes payable	145,022		95,127
Dividend payable	73,127		72,738
Other	181,929		192,152
	$	1,078,998	$	969,361

XML

LONG-TERM DEBT AND OTHER BORROWINGS

3 Months Ended

Sep. 24, 2017

Debt Disclosure [Abstract]

LONG-TERM DEBT AND OTHER BORROWINGS

LONG-TERM DEBT AND OTHER BORROWINGS

As of September 24, 2017, and June 25, 2017, the Company’s outstanding debt consisted of the following:

	September 24, 2017						June 25, 2017
	Amount (in thousands)				Effective Interest Rate		Amount (in thousands)				Effective Interest Rate
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes")	$	238,367		(1)	5.27	%	$	447,436		(2)	5.27	%
Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes")	500,000				2.88	%	500,000				2.88	%
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000				2.95	%	800,000				2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000				3.87	%	500,000				3.87	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	538,468			(1)	4.28	%	631,074			(2)	4.28	%
Total debt outstanding, at par	2,576,835						2,878,510
Unamortized discount	(145,241		)				(178,589		)
Fair value adjustment - interest rate contracts	(12,761		)				(10,102		)
Unamortized bond issuance costs	(2,798		)				(3,161		)
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658
Reported as:
Current portion of long-term debt	$	639,252		(3)			$	907,827		(3)
Long-term debt	1,776,783						1,778,831
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658

____________________________

⁽¹⁾ As of September 24, 2017, these notes were convertible at the option of the bondholder, as a result of the condition described in (3) below. Upon closure of the conversion period, the 2041 Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity.

⁽²⁾ As of June 25, 2017, these notes were convertible at the option of the bond holder, as a result of the condition described in (3) below.

⁽³⁾ As of the report date, the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets.

Convertible Senior Notes

In May 2011, the Company issued and sold $450 million in aggregate principal amount of 1.25% Convertible Senior Notes due May 2018 (the “2018 Notes”) at par. The Company pays cash interest at an annual rate of 1.25%, on a semi-annual basis on May 15 and November 15 of each year.

In June 2012, with the acquisition of Novellus Systems, Inc. (“Novellus”), the Company assumed $700 million in aggregate principal amount of 2.625% Convertible Senior Notes due May 2041 (the “2041 Notes,” and collectively with the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of 2.625%, on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to 0.60% per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.

The Company separately accounts for the liability and equity components of the Convertible Notes. The initial debt components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.

Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. The principal value of Convertible Note conversions in the three months ended September 24, 2017, was approximately $301.7 million.

Selected additional information regarding the Convertible Notes outstanding as of September 24, 2017, and June 25, 2017, is as follows:

	September 24, 2017				June 25, 2017
	2018 Notes		2041 Notes		2018 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	92,388	$	157,210	$	89,604	$	156,374
Carrying amount of temporary equity component, net of tax	$	5,816	$	131,180	$	15,186	$	154,675
Remaining amortization period (years)	0.6		23.6		0.8		23.8
Fair Value of Notes (Level 2)	$	697,829	$	2,805,294
Conversion rate (shares of common stock per $1,000 principal amount of notes)	16.6142		29.8160
Conversion price (per share of common stock)	$	60.19	$	33.54
If-converted value in excess of par value	$	461,533	$	2,298,926
Estimated share dilution using average quarterly stock price $159.71 per share	2,468		12,683

Convertible Note Hedges and Warrants

Concurrent with the issuance of the 2018 Notes the Company purchased a convertible note hedge and sold warrants. The warrants settlement is contractually defined as net share settlement. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. As of September 24, 2017, the warrants associated with the 2018 Notes had not been exercised and remained outstanding.

In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. During the period ended September 24, 2017 the note hedge was partially settled, resulting in the receipt of approximately 2,092,000 shares.

The following table presents the details of the warrants and convertible note hedge arrangements as of September 24, 2017:

	2018 Notes
	(shares in thousands)
Warrants:
Underlying shares	7,476
Estimated share dilution using average quarterly stock price $159.71 per share	4,074
Exercise price	$	72.69
Expiration date range	August 15 - October 24, 2018
Convertible Note Hedge:
Number of shares available from counterparties	3,960
Exercise price	$	60.19

Senior Notes

On March 12, 2015, the Company completed a public offering of $500 million aggregate principal amount of the Company’s Senior Notes due March, 2020 (the “2020 Notes”) and $500 million aggregate principal amount of the Company’s Senior Notes due March, 2025 (the “2025 Notes”, together with the 2020 Notes, the “Senior Notes”). The Company pays interest at an annual rate of 2.75% and 3.80%, on the 2020 Notes and 2025 Notes, respectively, on a semi-annual basis on March 15 and September 15 of each year. During the year ended June 26, 2016, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 7 for additional information regarding these interest rate contracts.

The Company may redeem the Senior Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before February 15, 2020, for the 2020 Notes and before December 15, 2024, for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020, for the 2020 Notes and on or after December 24, 2024, for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the principal amount of the Senior Notes, plus accrued and unpaid interest.

On June 7, 2016, The Company completed a public offering of $800 million aggregate principal amount of Senior Notes due June 2021 (the “2021 Notes”, together with the 2020 and 2025 Notes, the “Senior Notes”). The Company pays interest at an annual rate of 2.80% on the 2021 Notes on a semi-annual basis on June 15 and December 15 of each year.

The Company may redeem the 2021 Notes at a redemption price equal to 100% of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes and accrued and unpaid interest before May 15, 2021. The Company may redeem the 2021 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the 2021 Notes at a price equal to 101% of the principal amount of the respective note, plus accrued and unpaid interest.

Selected additional information regarding the Senior Notes outstanding as of September 24, 2017, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2020 Notes	2.5	$	507,915
2021 Notes	3.7	$	810,384
2025 Notes	7.5	$	518,625

Interest Cost

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the three months ended September 24, 2017, and September 25, 2016.

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Contractual interest coupon	$	17,956		$	34,712
Amortization of interest discount	4,104			5,914
Amortization of issuance costs	485			918
Effect of interest rate contracts, net	(349		)	(1,058		)
Total interest cost recognized	$	22,196		$	40,486

Revolving Credit Facility

On November 10, 2015, the Company entered into an Amendment and Restatement Agreement (as amended on April 26, 2016, by Amendment No. 1 to the Amended and Restated Credit Agreement, and as further amended, restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates the Company’s prior unsecured Credit Agreement, dated March 12, 2014 (as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from $300.0 million to $750.0 million with a syndicate of lenders. It includes an expansion option, subject to certain requirements, for us to request an increase in the facility of up to an additional $250.0 million, for a potential total commitment of $1.0 billion. Proceeds from the credit facility can be used for general corporate purposes. The facility matures on November 10, 2020.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) one-month LIBOR plus 1.0%, plus a spread of 0.0% to 0.5%, or (2) LIBOR multiplied by the statutory rate, plus a spread of 0.9% to 1.5% in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default that are substantially similar to those in the Amended and Restated Term Loan Agreement. As of September 24, 2017, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

On October 13, 2017, the Company entered into Amendment No. 2 to Amended and Restated Credit Agreement (the “2nd Amendment”), among the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends the Company’s Credit Agreement (as amended by the 2nd Amendment, the “Amended Credit Agreement”).

Among other things, the Amended Credit Agreement provides for a $500 million increase to the Company’s revolving credit facility, from $750 million under the Credit Agreement to $1.25 billion under the Amended Credit Agreement. The Amended Credit Agreement also modifies the date of maturity of the revolving credit facility from November 10, 2020 to October 13, 2022. The Amended Credit Agreement provides for an expansion option that will allow the Company, subject to certain requirements, to request an increase in the facility of up to an additional $600 million, for a potential total commitment of $1.85 billion. Other than as disclosed in this paragraph, the material terms of the Amended Credit Agreement are substantially the same as the Credit Agreement.

XML

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Sep. 24, 2017

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

Operating Leases and Related Guarantees

The Company leases the majority of its administrative, research and development (“R&D”) and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company was required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of September 24, 2017.

During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than approximately $220.4 million; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of the lessor’s aggregate investment in the applicable property, which in no case will exceed $250.0 million, in the aggregate.

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into certain insurance contracts that are intended to limit its exposure to such indemnifications. As of September 24, 2017, the Company had not recorded any liability in connection with these indemnifications, as it does not believe that it is probable that any amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of September 24, 2017, the maximum potential amount of future payments that it could be required to make under these arrangements and letters of credit was $20.6 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Balance at beginning of period	$	161,981		$	100,321
Warranties issued during the period	48,790			34,855
Settlements made during the period	(44,053		)	(32,228		)
Changes in liability for pre-existing warranties	1,619			278
Balance at end of period	$	168,337		$	103,226

Legal proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual for litigation or other contingencies related to existing legal proceedings.

XML

STOCK REPURCHASE PROGRAM

3 Months Ended

Sep. 24, 2017

Equity [Abstract]

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM

In November 2016, the Board of Directors authorized the repurchase of up to $1.0 billion of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases are funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 25, 2017						$	282,141
Quarter ended September 24, 2017	1,779	$	157,938	$	158.40	$	124,203

(1) Average price paid per share excludes effect of accelerated share repurchases; see additional disclosure below regarding our accelerated share repurchase activity during the fiscal year.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three months ended September 24, 2017, the Company acquired 11 thousand shares at a total cost of $1.8 million which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

On April 19, 2017, the Company entered into two separate accelerated share repurchase agreements (collectively, the “ASR”) with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 2,570,000 shares, which represented 70% of the prepayment amount divided by the Company’s closing stock price on April 19, 2017. The total number of shares to be received under the ASR was based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Following the fiscal year end, the counterparties designated June 30, 2017 as the termination date, at which time the Company settled the ASR. Approximately 780,000 shares were received at final settlement, which resulted in a weighted-average share price of approximately $149.16 for the transaction period.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

3 Months Ended

Sep. 24, 2017

Equity [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows:

	Accumulated Foreign Currency Translation Adjustment				Accumulated Unrealized  Holding Gain (Loss) on Cash flow hedges				Accumulated Unrealized  Holding Gain (Loss) on Available-For-Sale  Investments				Accumulated Unrealized  Components of Defined  Benefit Plans			Total
	(in thousands)
Balance as of June 25, 2017	$	(42,371	)		$	(811	)		$	1,106			$	(19,624	)	$	(61,700	)
Other comprehensive income (loss) before reclassifications	7,886				3,062				(1,727		)		(2,356		)	6,865
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income	(17		)	(1)	2,188			(2)	(123		)	(1)	—			2,048
Net current-period other comprehensive income (loss)	$	7,869			$	5,250			$	(1,850	)		$	(2,356	)	$	8,913
Balance as of September 24, 2017	$	(34,502	)		$	4,439			$	(744	)		$	(21,980	)	$	(52,787	)

(1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.

(2) Amount of after tax gain reclassified from AOCI into net income located in revenue: $3,383 loss; cost of goods sold: $678 gain; selling, general, and administrative expenses: $537 gain; and other income and expense: $20 loss.

XML

BUSINESS COMBINATIONS

3 Months Ended

Sep. 24, 2017

Business Combinations [Abstract]

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS

On August 28, 2017, the Company completed the acquisition of the outstanding shares of Coventor, Inc. (“Coventor”), a privately-held company that is a provider of simulation and modeling solutions for semiconductor process technology, micro-electromechanical systems (MEMS), and the Internet of Things, for a total purchase consideration of $137.6 million.

The following table represents the preliminary purchase price allocation and summarizes the aggregate estimated fair value of the net assets acquired on the closing date of the acquisition:

	Preliminary Purchase Price Allocation
	(In thousands)
Intangible assets	$	48,500
Assets acquired (including cash of $8.7 million)	12,796
Goodwill	97,832
Liabilities assumed	(21,517		)
Fair value of net assets acquired	$	137,611

The preliminary fair values of net tangible and intangible assets acquired were based on preliminary valuations, and management’s estimates and assumptions are subject to change within the measurement period (up to one year from the acquisition date). The primary area that remains open relates to the fair value of intangible assets, certain tangible assets and liabilities assumed and income taxes. The Company expects to continue to obtain information to assist us in determining the fair value of the net assets acquired during the measurement period.

The operating results of the acquired entity, from the date of acquisition, have been included in the Company’s Condensed Consolidated Financial Statements for the three months ended September 24, 2017. Goodwill represents the excess of the purchase price over the net tangible and identifiable intangible assets acquired. None of the goodwill recognized is deductible for income tax purposes.

The identified intangible assets assumed in the acquisition of Coventor were recognized as follows based upon their fair values as of August 28, 2017:

	Fair Value		Weighted-Average Estimated Useful Life
	(In thousands)		(In years)
Existing technology	$	26,200	6.0
Customer relationships	15,000		6.0
Trade names and other intangible assets	7,300		6.4
Total identified intangible assets	$	48,500	6.0

Acquired existing technology represents the fair value of products that have reached technological feasibility and are a part of Coventor’s product offerings and customer relationships represent the fair values of the underlying relationships and agreements with Coventor’s customers.

XML

BASIS OF PRESENTATION (Policies)

3 Months Ended

Sep. 24, 2017

Accounting Policies [Abstract]

Consolidation

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Fiscal period

The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 24, 2018 and includes 52 weeks.

Recent accounting pronouncements

Recently Adopted

In November 2015, the Financial Accounting Standards Board (“FASB”) issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The Company adopted this standard prospectively in the first quarter of fiscal year 2018. The implementation resulted in a net reduction of prepaid expense and other current assets of $49.7 million, accrued expense and other current liabilities of $5.3 million, and other long-term liabilities of $39.4 million; and an increase in other assets of $5.0 million in the Company’s Condensed Consolidated Balance Sheet, and had no impact on cash provided by or used in operations for any period presented.

In March 2016, the FASB released ASU 2016-9, “Compensation – Stock Compensation.” Key changes in the amendment include:

• entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating additional paid in capital (“APIC”) pools;

• entities will no longer be required to delay recognition of excess tax benefits until they are realized;

• entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows;

• entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur;

• entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability; and

• the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows.

The Company adopted this standard in the first quarter of fiscal year 2018. As a result of the adoption, the Company recorded a $40.9 million cumulative-effect adjustment to retained earnings for the recognition of previously unrecognized excess tax benefits for all years prior to the adoption. As required by the standard update, the amendment was applied prospectively to recognize excess tax benefits or deficiencies in the income statement in the period of occurrence. Additionally, the Company has elected to apply the change in cash flow classification on a prospective basis. The Company has elected to continue to estimate the number of forfeitures expected to occur to determine the amount of compensation cost to be recognized each period. The Company has elected to adopt the effects of the standard update with regard to the income tax withholdings obligations on a prospective basis, such withholdings in the period ended September 24, 2017 were not material.

Updates Not Yet Effective

In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers,” to supersede nearly all existing revenue recognition guidance under GAAP. The FASB issued subsequent amendments to the initial guidance in August 2015, March 2016, April 2016, May 2016 and December 2016 within ASU 2015-14, ASU 2016-08, ASU 2016-10, ASU 2016-12 and ASU 2016-20, respectively. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each separate performance obligation.

The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (1) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (2) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method. The Company is continuing its evaluation of the impact that the new standard will have on its Condensed Consolidated Financial Statements and disclosures, business processes, systems, and controls. While the Company’s evaluation of the impact of the standard on its financial statements with respect to its spare parts and service revenue has not been completed, the Company believes that the timing of revenue recognition for certain of its systems will generally be earlier than under existing revenue recognition guidance. The Company continues to evaluate the impact to its revenues related to its pending adoption of these standards and its preliminary assessments are subject to change.

In January 2016, the FASB released ASU 2016-1, “Financial Instruments – Overall – Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity’s other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact on its Condensed Consolidated Financial Statements.

In January 2016, the FASB released ASU 2016-2, “Leases.” The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In June 2016, the FASB released ASU 2016-13, “Financial Instruments – Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2016, the FASB released ASU 2016-15, “Statement of Cash Flows – Classification of Certain Cash Receipts and Cash Payments.” The amendment provides and clarifies guidance on the classification of certain cash receipts and cash payments in the statement of cash flows to eliminate diversity in practice. The Company is required to adopt the standard update in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In October 2016, the FASB released ASU 2016-16, “Income Tax – Intra-Entity Transfers of Assets Other than Inventory.” This standard update improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Early adoption is permitted. The Company is required to adopt the standard in the first quarter of fiscal year 2019. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In November 2016, the FASB released ASU 2016-18, “Statement of Cash Flows – Restricted Cash.” This standard update requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company is required to adopt this standard in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

In August 2017, the FASB released ASU 2017-12, “Targeted Improvements to Accounting for Hedging Activities.” The new guidance is intended to: (1) more closely align hedge accounting with an entity’s risk management strategies, (2) simplify the application of hedge accounting by eliminating the requirement to separately measure and report hedge ineffectiveness, and (3) increase transparency around the scope and results of hedging programs. The Company is required to adopt the standard in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

XML

EQUITY-BASED COMPENSATION PLANS (Tables)

3 Months Ended

Sep. 24, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Recognized Equity Based Compensation Expense and Related Income Tax Benefit

The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands)
Equity-based compensation expense	$	41,783	$	38,595
Income tax benefit recognized related to equity-based compensation expense	$	13,387	$	10,905

XML

OTHER EXPENSE, NET (Tables)

3 Months Ended

Sep. 24, 2017

Other Income and Expenses [Abstract]

Components of Other Expense, Net

The significant components of other expense, net, are as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Interest income	$	20,209		$	12,763
Interest expense	(23,905		)	(41,429		)
Gains on deferred compensation plan related assets, net	3,453			6,172
Foreign exchange (losses) gains, net	(3,000		)	1,219
Other, net	(2,259		)	(1,879		)
	$	(5,502	)	$	(23,154	)

XML

NET INCOME PER SHARE (Tables)

3 Months Ended

Sep. 24, 2017

Earnings Per Share [Abstract]

Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share

The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share. 

	Three Months Ended
	September 24, 2017		September 25, 2016
	(in thousands, except per share data)
Numerator:
Net income	$	590,690	$	263,835
Denominator:
Basic average shares outstanding	162,141		160,607
Effect of potential dilutive securities:
Employee stock plans	2,514		2,142
Convertible notes	15,151		15,220
Warrants	4,074		2,048
Diluted average shares outstanding	183,880		180,017
Net income per share - basic	$	3.64	$	1.64
Net income per share - diluted	$	3.21	$	1.47

Schedule of Potentially Dilutive Securities Excluded from EPS Calculations

The following potentially dilutive securities were excluded:

	Three Months Ended
	September 24, 2017	September 25, 2016
	(in thousands)
Number of options and RSUs excluded	7	196

XML

FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Sep. 24, 2017

Fair Value Disclosures [Abstract]

Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis

The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of September 24, 2017, and June 25, 2017:

	September 24, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	543,990	$	—	$	—		$	543,990	$	537,972	$	—	$	6,018	$	—
Level 1:
Time deposit	693,205		—		—			693,205		443,178		—		250,027		—
Money market funds	1,395,032		—		—			1,395,032		1,395,032		—		—		—
U.S. Treasury and agencies	821,441		265		(2,569		)	819,137		15,648		803,489		—		—
Mutual funds	53,131		3,125		(70		)	56,186		—		—		—		56,186
Level 1 Total	2,962,809		3,390		(2,639		)	2,963,560		1,853,858		803,489		250,027		56,186
Level 2:
Municipal notes and bonds	165,029		322		(21		)	165,330		—		165,330		—		—
U.S. Treasury and agencies	12,798		—		(102		)	12,696		—		12,696		—		—
Government-sponsored enterprises	55,845		—		(322		)	55,523		—		55,523		—		—
Foreign government bonds	67,040		90		(128		)	67,002		—		67,002		—		—
Corporate notes and bonds	2,532,374		4,020		(2,376		)	2,534,018		14,632		2,519,386		—		—
Mortgage backed securities — residential	46,614		63		(116		)	46,561		—		46,561		—		—
Mortgage backed securities — commercial	106,173		40		(275		)	105,938		—		105,938		—		—
Level 2 Total	2,985,873		4,535		(3,340		)	2,987,068		14,632		2,972,436		—		—
Total	$	6,492,672	$	7,925	$	(5,979	)	$	6,494,618	$	2,406,462	$	3,775,925	$	256,045	$	56,186

	June 25, 2017
										(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)			Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Cash	$	551,308	$	—	$	—		$	551,308	$	545,130	$	—	$	6,178	$	—
Level 1:
Time deposit	640,666		—		—			640,666		390,639		—		250,027		—
Money market funds	1,423,417		—		—			1,423,417		1,423,417		—		—		—
U.S. Treasury and agencies	783,848		684		(2,111		)	782,421		8,297		774,124		—		—
Mutual funds	53,247		3,007		—			56,254		—		—		—		56,254
Level 1 Total	2,901,178		3,691		(2,111		)	2,902,758		1,822,353		774,124		250,027		56,254
Level 2:
Municipal notes and bonds	194,575		308		(7		)	194,876		—		194,876		—		—
U.S. Treasury and agencies	12,795		—		(167		)	12,628		—		12,628		—		—
Government-sponsored enterprises	24,502		—		(6		)	24,496		—		24,496		—		—
Foreign government bonds	62,917		219		(114		)	63,022		—		63,022		—		—
Corporate notes and bonds	2,433,622		4,654		(1,840		)	2,436,436		10,051		2,426,385		—		—
Mortgage backed securities — residential	102,760		87		(489		)	102,358		—		102,358		—		—
Mortgage backed securities — commercial	65,828		9		(98		)	65,739		—		65,739		—		—
Level 2 Total	2,896,999		5,277		(2,721		)	2,899,555		10,051		2,889,504		—		—
Total	$	6,349,485	$	8,968	$	(4,832	)	$	6,353,621	$	2,377,534	$	3,663,628	$	256,205	$	56,254

Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments in Unrealized Loss Positions

The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions:

	September 24, 2017
	Unrealized Losses Less than 12 Months					Unrealized Losses 12 Months or Greater					Total
	Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss			Fair Value		Gross Unrealized Loss
	(in thousands)
U.S. Treasury and agencies	$	660,429	$	(2,671	)	$	—	$	—		$	660,429	$	(2,671	)
Municipal notes and bonds	18,653		(21		)	—		—			18,653		(21		)
Mutual funds	3,122		(70		)	—		—			3,122		(70		)
Government-sponsored enterprises	55,297		(322		)	—		—			55,297		(322		)
Foreign government bonds	33,729		(128		)	—		—			33,729		(128		)
Corporate notes and bonds	1,282,655		(2,376		)	—		—			1,282,655		(2,376		)
Mortgage backed securities — residential	30,210		(93		)	2,006		(23		)	32,216		(116		)
Mortgage backed securities — commercial	98,303		(261		)	2,634		(14		)	100,937		(275		)
	$	2,182,398	$	(5,942	)	$	4,640	$	(37	)	$	2,187,038	$	(5,979	)

Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, Restricted Cash and Investments with Contractual Maturities

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of September 24, 2017:

	Cost		Estimated Fair Value
	(in thousands)
Due in one year or less	$	2,764,552	$	2,764,415
Due after one year through five years	2,987,295		2,986,525
Due in more than five years	143,704		143,502
	$	5,895,551	$	5,894,442

Schedule of Outstanding Foreign Currency Forward Contracts

As of September 24, 2017, the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge programs:

	Notional Value
	Derivatives Designated as Hedging Instruments:				Derivatives Not Designated as Hedging Instruments:
	(in thousands)
Foreign currency forward contracts
	Buy Contracts		Sell Contracts		Buy Contracts		Sell Contracts
Japanese yen	$	—	$	393,345	$	—	$	282,311
Euro	31,917		—		31,246		—
Korean won	13,536		—		—		84,122
Taiwan dollar	—		—		12,658		—
Swiss franc	—		—		9,375		—
Chinese renminbi	—		—		7,137
Singapore dollar	—		—		4,469		—
	$	45,453	$	393,345	$	64,885	$	366,433
Foreign currency option contracts
	Buy Put		Sell Put		Buy Put(1)		Sell Put
Japanese yen	$	36,036	$	—	$	8,929	$	8,929

(1) Contracts were entered into and designated as cash flow hedges under ASC 815 at contract inception as part of the Company’s cash flow hedge program. The contracts were subsequently de-designated; changes in fair market value subsequent to de-designation effect current earnings.

Schedule of Fair Value of Derivatives Instruments

The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of September 24, 2017, and June 25, 2017 were as follows:

	September 24, 2017						June 25, 2017
	Fair Value of Derivative Instruments (Level 2)						Fair Value of Derivative Instruments (Level 2)
	Asset Derivatives			Liability Derivatives			Asset Derivatives			Liability Derivatives
	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
	(in thousands)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	$	9,598	Accrued expenses and other current liabilities	$	368	Prepaid expense and other assets	$	8,061	Accrued expenses and other current liabilities	$	2,916
Interest rate contracts, short-term	Prepaid expense and other assets	316								Accrued expenses and other current liabilities	2,833
Interest rate contracts, long-term				Other long-term liabilities	13,077					Other long-term liabilities	7,269
Derivatives not designated as hedging instruments:
Foreign exchange forward contracts	Prepaid expense and other assets	109		Accrued expenses and other current liabilities	461		Prepaid expense and other assets	213		Accrued expenses and other current liabilities	342
Total Derivatives		$	10,023		$	13,906		$	8,274		$	13,360

Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations

The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:

		Three Months Ended September 24, 2017									Three Months Ended September 25, 2016
		Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness			Effective Portion						Ineffective  Portion and Amount Excluded from Effectiveness
Derivatives Designated as Hedging Instruments	Location of  Gain (Loss) Recognized  in or  Reclassified into Income	(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income			(Loss) Gain Recognized in AOCI			(Loss) Gain Reclassified from AOCI into Income			Gain (Loss) Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Revenue	$	(9	)	$	(3,806	)	$	2,547		$	(2,913	)	$	(13,605	)	$	705
Foreign Exchange Contracts	Cost of goods sold	2,443			824			(208		)	235			173			(67		)
Foreign Exchange Contracts	Selling, general, and administrative	1,356			714			(117		)	(24		)	(9		)	(21		)
Foreign Exchange Contracts	Other expense, net	—			—			(17		)	—			—			—
Interest Rate Contracts	Other expense, net	—			(31		)	—			—			9			—
		$	3,790		$	(2,299	)	$	2,205		$	(2,702	)	$	(13,432	)	$	617

The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:

		Three Months Ended
		September 24, 2017		September 25, 2016
Derivatives Not Designated as Hedging Instruments:	Location  of Gain (Loss) Recognized  in Income	Gain Recognized in Income		Loss Recognized in Income
		(in thousands)
Foreign Exchange Contracts	Other  income	$	2,672	$	(383	)

XML

INVENTORIES (Tables)

3 Months Ended

Sep. 24, 2017

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Raw materials	$	721,352	$	625,600
Work-in-process	200,271		213,066
Finished goods	406,674		394,250
	$	1,328,297	$	1,232,916

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

3 Months Ended

Sep. 24, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The following table provides the Company’s intangible assets:

	September 24, 2017							June 25, 2017
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
	(in thousands)
Customer relationships	$	630,257	$	(383,131	)	$	247,126	$	615,164	$	(366,439	)	$	248,725
Existing technology	669,603		(508,983		)	160,620		643,196		(487,056		)	156,140
Patents	36,553		(31,872		)	4,681		36,553		(31,238		)	5,315
Other intangible assets	43,814		(35,882		)	7,932		36,514		(35,699		)	815
Total intangible assets	$	1,380,227	$	(959,868	)	$	420,359	$	1,331,427	$	(920,432	)	$	410,995

Estimated Future Amortization Expense of Intangible Assets

The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of September 24, 2017, was as follows:

Fiscal Year	Amount
	(in thousands)
2018 (remaining 9 months)	$	121,147
2019	123,429
2020	58,296
2021	55,611
2022	51,801
Thereafter	10,075
	$	420,359

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

3 Months Ended

Sep. 24, 2017

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	September 24, 2017		June 25, 2017
	(in thousands)
Accrued compensation	$	510,583	$	447,363
Warranty reserves	168,337		161,981
Income and other taxes payable	145,022		95,127
Dividend payable	73,127		72,738
Other	181,929		192,152
	$	1,078,998	$	969,361

XML

LONG-TERM DEBT AND OTHER BORROWINGS (Tables)

3 Months Ended

Sep. 24, 2017

Debt Disclosure [Abstract]

Schedule of Outstanding Debt

As of September 24, 2017, and June 25, 2017, the Company’s outstanding debt consisted of the following:

	September 24, 2017						June 25, 2017
	Amount (in thousands)				Effective Interest Rate		Amount (in thousands)				Effective Interest Rate
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes")	$	238,367		(1)	5.27	%	$	447,436		(2)	5.27	%
Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes")	500,000				2.88	%	500,000				2.88	%
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")	800,000				2.95	%	800,000				2.95	%
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")	500,000				3.87	%	500,000				3.87	%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")	538,468			(1)	4.28	%	631,074			(2)	4.28	%
Total debt outstanding, at par	2,576,835						2,878,510
Unamortized discount	(145,241		)				(178,589		)
Fair value adjustment - interest rate contracts	(12,761		)				(10,102		)
Unamortized bond issuance costs	(2,798		)				(3,161		)
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658
Reported as:
Current portion of long-term debt	$	639,252		(3)			$	907,827		(3)
Long-term debt	1,776,783						1,778,831
Total debt outstanding, at carrying value	$	2,416,035					$	2,686,658

____________________________

⁽¹⁾ As of September 24, 2017, these notes were convertible at the option of the bondholder, as a result of the condition described in (3) below. Upon closure of the conversion period, the 2041 Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity.

⁽²⁾ As of June 25, 2017, these notes were convertible at the option of the bond holder, as a result of the condition described in (3) below.

⁽³⁾ As of the report date, the market value of the Company’s Common Stock was greater than 130% of the convertible notes conversion price for 20 or more of the 30 consecutive trading days preceding the quarter-end. As a result, the 2041 Notes were classified in current liabilities and a portion of the equity component, associated with the convertible notes representing the unamortized discount, was classified in temporary equity on the Company’s Consolidated Balance Sheets.

Components of Convertible Notes

Selected additional information regarding the Convertible Notes outstanding as of September 24, 2017, and June 25, 2017, is as follows:

	September 24, 2017				June 25, 2017
	2018 Notes		2041 Notes		2018 Notes		2041 Notes
	(in thousands, except years, percentages, conversion rate, and conversion price)
Carrying amount of permanent equity component, net of tax	$	92,388	$	157,210	$	89,604	$	156,374
Carrying amount of temporary equity component, net of tax	$	5,816	$	131,180	$	15,186	$	154,675
Remaining amortization period (years)	0.6		23.6		0.8		23.8
Fair Value of Notes (Level 2)	$	697,829	$	2,805,294
Conversion rate (shares of common stock per $1,000 principal amount of notes)	16.6142		29.8160
Conversion price (per share of common stock)	$	60.19	$	33.54
If-converted value in excess of par value	$	461,533	$	2,298,926
Estimated share dilution using average quarterly stock price $159.71 per share	2,468		12,683

Warrants and Convertible Note Hedge Arrangements

The following table presents the details of the warrants and convertible note hedge arrangements as of September 24, 2017:

	2018 Notes
	(shares in thousands)
Warrants:
Underlying shares	7,476
Estimated share dilution using average quarterly stock price $159.71 per share	4,074
Exercise price	$	72.69
Expiration date range	August 15 - October 24, 2018
Convertible Note Hedge:
Number of shares available from counterparties	3,960
Exercise price	$	60.19

Schedule of Carrying Values and Estimated Fair Values of Debt Instruments

Selected additional information regarding the Senior Notes outstanding as of September 24, 2017, is as follows: 

	Remaining Amortization period	Fair Value of Notes (Level 2)
	(years)	(in thousands)
2020 Notes	2.5	$	507,915
2021 Notes	3.7	$	810,384
2025 Notes	7.5	$	518,625

Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes

The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the three months ended September 24, 2017, and September 25, 2016.

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Contractual interest coupon	$	17,956		$	34,712
Amortization of interest discount	4,104			5,914
Amortization of issuance costs	485			918
Effect of interest rate contracts, net	(349		)	(1,058		)
Total interest cost recognized	$	22,196		$	40,486

XML

COMMITMENTS AND CONTINGENCIES (Tables)

3 Months Ended

Sep. 24, 2017

Commitments and Contingencies Disclosure [Abstract]

Warranties

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended
	September 24, 2017			September 25, 2016
	(in thousands)
Balance at beginning of period	$	161,981		$	100,321
Warranties issued during the period	48,790			34,855
Settlements made during the period	(44,053		)	(32,228		)
Changes in liability for pre-existing warranties	1,619			278
Balance at end of period	$	168,337		$	103,226

XML

STOCK REPURCHASE PROGRAM (Tables)

3 Months Ended

Sep. 24, 2017

Equity [Abstract]

Repurchases Under the Repurchase Program

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased	Total Cost of Repurchase		Average Price Paid Per Share (1)		Amount Available Under Repurchase Program
	(in thousands, except per share data)
Available balance as of June 25, 2017						$	282,141
Quarter ended September 24, 2017	1,779	$	157,938	$	158.40	$	124,203

(1) Average price paid per share excludes effect of accelerated share repurchases; see additional disclosure below regarding our accelerated share repurchase activity during the fiscal year.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

3 Months Ended

Sep. 24, 2017

Equity [Abstract]

Components of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows:

	Accumulated Foreign Currency Translation Adjustment				Accumulated Unrealized  Holding Gain (Loss) on Cash flow hedges				Accumulated Unrealized  Holding Gain (Loss) on Available-For-Sale  Investments				Accumulated Unrealized  Components of Defined  Benefit Plans			Total
	(in thousands)
Balance as of June 25, 2017	$	(42,371	)		$	(811	)		$	1,106			$	(19,624	)	$	(61,700	)
Other comprehensive income (loss) before reclassifications	7,886				3,062				(1,727		)		(2,356		)	6,865
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income	(17		)	(1)	2,188			(2)	(123		)	(1)	—			2,048
Net current-period other comprehensive income (loss)	$	7,869			$	5,250			$	(1,850	)		$	(2,356	)	$	8,913
Balance as of September 24, 2017	$	(34,502	)		$	4,439			$	(744	)		$	(21,980	)	$	(52,787	)

(1) Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.

(2) Amount of after tax gain reclassified from AOCI into net income located in revenue: $3,383 loss; cost of goods sold: $678 gain; selling, general, and administrative expenses: $537 gain; and other income and expense: $20 loss.

XML

BUSINESS COMBINATIONS (Tables)

3 Months Ended

Sep. 24, 2017

Business Combinations [Abstract]

Schedule of Preliminary Purchase Price Allocation

The following table represents the preliminary purchase price allocation and summarizes the aggregate estimated fair value of the net assets acquired on the closing date of the acquisition:

	Preliminary Purchase Price Allocation
	(In thousands)
Intangible assets	$	48,500
Assets acquired (including cash of $8.7 million)	12,796
Goodwill	97,832
Liabilities assumed	(21,517		)
Fair value of net assets acquired	$	137,611

Schedule of Identified Intangible Assets Assumed in the Acquisition

The identified intangible assets assumed in the acquisition of Coventor were recognized as follows based upon their fair values as of August 28, 2017:

	Fair Value		Weighted-Average Estimated Useful Life
	(In thousands)		(In years)
Existing technology	$	26,200	6.0
Customer relationships	15,000		6.0
Trade names and other intangible assets	7,300		6.4
Total identified intangible assets	$	48,500	6.0

XML

RECENT ACCOUNTING PRONOUNCEMENTS (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017	[1]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Prepaid expenses and other current assets	$ 187,334	$ 195,022
Accrued expenses and other current liabilities	1,078,998	969,361
Other long-term liabilities	(278,733)	(280,186)
Other assets	263,812	$ 241,799
ASU 2015-17
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Prepaid expenses and other current assets	(49,700)
Accrued expenses and other current liabilities	(5,300)
Other long-term liabilities	39,400
Other assets	5,000
ASU 2016-9 | Retained earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative-effect adjustment to retained earnings	$ 40,900

[1] Derived from audited financial statements

XML

EQUITY-BASED COMPENSATION PLANS - Additional Information (Details)	3 Months Ended
	Sep. 24, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Options and restricted stock units vesting period (years)	3 years

XML

EQUITY-BASED COMPENSATION PLANS - Recognized Equity Based Compensation Expenses and Related Income Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Equity-based compensation expense	$ 41,783	$ 38,595
Income tax benefit recognized related to equity-based compensation expense	$ 13,387	$ 10,905

XML

OTHER EXPENSE, NET (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Other Income and Expenses [Abstract]
Interest income	$ 20,209	$ 12,763
Interest expense	(23,905)	(41,429)
Gains on deferred compensation plan related assets, net	3,453	6,172
Foreign exchange (losses) gains, net	(3,000)	1,219
Other, net	(2,259)	(1,879)
Other expense, net	$ (5,502)	$ (23,154)

XML

INCOME TAX EXPENSE (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Income Tax Disclosure [Abstract]
Income tax expense	$ 97,030	$ 28,958
Effective income tax rate	14.10%
U.S. federal statutory tax rate	35.00%
Tax examinations or lapses of statute of limitation | Minimum
Income Tax Contingency [Line Items]
Estimated unrecognized tax benefits reduction	$ 15,000
Tax examinations or lapses of statute of limitation | Maximum
Income Tax Contingency [Line Items]
Estimated unrecognized tax benefits reduction	$ 50,000

XML

NET INCOME PER SHARE - Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Numerator:
Net income	$ 590,690	$ 263,835
Denominator:
Basic average shares outstanding (in shares)	162,141	160,607
Effect of potential dilutive securities:
Employee stock plans (in shares)	2,514	2,142
Convertible notes (in shares)	15,151	15,220
Warrants (in shares)	4,074	2,048
Diluted average shares outstanding (in shares)	183,880	180,017
Net income per share - basic (in dollars per share)	$ 3.64	$ 1.64
Net income per share - diluted (in dollars per share)	$ 3.21	$ 1.47

XML

NET INCOME PER SHARE - Schedule of Potentially Dilutive Securities Excluded from EPS Calculations (Details) - shares shares in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Earnings Per Share [Abstract]
Number of options and RSUs excluded (in shares)	7	196

XML

FINANCIAL INSTRUMENTS - Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	$ 6,492,672	$ 6,349,485
Unrealized Gain	7,925	8,968
Unrealized (Loss)	(5,979)	(4,832)
Fair Value	6,494,618	6,353,621
Cash and Cash Equivalents	2,406,462	2,377,534
Investments	3,775,925	3,663,628
Restricted Cash & Investments	256,045	256,205
Other Assets	56,186	56,254
Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	2,962,809	2,901,178
Unrealized Gain	3,390	3,691
Unrealized (Loss)	(2,639)	(2,111)
Fair Value	2,963,560	2,902,758
Cash and Cash Equivalents	1,853,858	1,822,353
Investments	803,489	774,124
Restricted Cash & Investments	250,027	250,027
Other Assets	56,186	56,254
Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	2,985,873	2,896,999
Unrealized Gain	4,535	5,277
Unrealized (Loss)	(3,340)	(2,721)
Fair Value	2,987,068	2,899,555
Cash and Cash Equivalents	14,632	10,051
Investments	2,972,436	2,889,504
Restricted Cash & Investments	0	0
Other Assets	0	0
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	543,990	551,308
Unrealized Gain	0	0
Unrealized (Loss)	0	0
Fair Value	543,990	551,308
Cash and Cash Equivalents	537,972	545,130
Investments	0	0
Restricted Cash & Investments	6,018	6,178
Other Assets	0	0
Time deposit | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	693,205	640,666
Unrealized Gain	0	0
Unrealized (Loss)	0	0
Fair Value	693,205	640,666
Cash and Cash Equivalents	443,178	390,639
Investments	0	0
Restricted Cash & Investments	250,027	250,027
Other Assets	0	0
Money market funds | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	1,395,032	1,423,417
Unrealized Gain	0	0
Unrealized (Loss)	0	0
Fair Value	1,395,032	1,423,417
Cash and Cash Equivalents	1,395,032	1,423,417
Investments	0	0
Restricted Cash & Investments	0	0
Other Assets	0	0
U.S. Treasury and agencies | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	821,441	783,848
Unrealized Gain	265	684
Unrealized (Loss)	(2,569)	(2,111)
Fair Value	819,137	782,421
Cash and Cash Equivalents	15,648	8,297
Investments	803,489	774,124
Restricted Cash & Investments	0	0
Other Assets	0	0
U.S. Treasury and agencies | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	12,798	12,795
Unrealized Gain	0	0
Unrealized (Loss)	(102)	(167)
Fair Value	12,696	12,628
Cash and Cash Equivalents	0	0
Investments	12,696	12,628
Restricted Cash & Investments	0	0
Other Assets	0	0
Mutual funds | Fair Value Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	53,131	53,247
Unrealized Gain	3,125	3,007
Unrealized (Loss)	(70)	0
Fair Value	56,186	56,254
Cash and Cash Equivalents	0	0
Investments	0	0
Restricted Cash & Investments	0	0
Other Assets	56,186	56,254
Municipal notes and bonds | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	165,029	194,575
Unrealized Gain	322	308
Unrealized (Loss)	(21)	(7)
Fair Value	165,330	194,876
Cash and Cash Equivalents	0	0
Investments	165,330	194,876
Restricted Cash & Investments	0	0
Other Assets	0	0
Government-sponsored enterprises | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	55,845	24,502
Unrealized Gain	0	0
Unrealized (Loss)	(322)	(6)
Fair Value	55,523	24,496
Cash and Cash Equivalents	0	0
Investments	55,523	24,496
Restricted Cash & Investments	0	0
Other Assets	0	0
Foreign government bonds | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	67,040	62,917
Unrealized Gain	90	219
Unrealized (Loss)	(128)	(114)
Fair Value	67,002	63,022
Cash and Cash Equivalents	0	0
Investments	67,002	63,022
Restricted Cash & Investments	0	0
Other Assets	0	0
Corporate notes and bonds | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	2,532,374	2,433,622
Unrealized Gain	4,020	4,654
Unrealized (Loss)	(2,376)	(1,840)
Fair Value	2,534,018	2,436,436
Cash and Cash Equivalents	14,632	10,051
Investments	2,519,386	2,426,385
Restricted Cash & Investments	0	0
Other Assets	0	0
Mortgage backed securities — residential | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	46,614	102,760
Unrealized Gain	63	87
Unrealized (Loss)	(116)	(489)
Fair Value	46,561	102,358
Cash and Cash Equivalents	0	0
Investments	46,561	102,358
Restricted Cash & Investments	0	0
Other Assets	0	0
Mortgage backed securities — commercial | Fair Value Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	106,173	65,828
Unrealized Gain	40	9
Unrealized (Loss)	(275)	(98)
Fair Value	105,938	65,739
Cash and Cash Equivalents	0	0
Investments	105,938	65,739
Restricted Cash & Investments	0	0
Other Assets	$ 0	$ 0

XML

FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016	Jun. 25, 2017
Fair Value Disclosures [Abstract]
Other than temporary impairment included in net realized gains (losses)	$ 0	$ 0
Gross realized gains from sale of investments	800,000	2,600,000
Gross realized losses from sale of investments	(1,000,000)	$ (200,000)
Foreign exchange forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange contracts amount of offset, assets	5,100,000
Foreign exchange contracts amount of offset, liabilities	5,100,000		$ 5,900,000
Net derivative asset from master netting agreements	4,900,000
Net derivative liability from master netting agreements	8,800,000
Foreign exchange forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Foreign exchange contracts amount of offset, assets			5,900,000
Net derivative asset from master netting agreements			2,300,000
Net derivative liability from master netting agreements			$ 7,400,000
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Gain reclassification from AOCI to income, in the next 12 months	$ 6,300,000
Foreign currency cash flow hedge, expiration period	12 months
Losses accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings	$ 1,900,000
Gains (losses) accumulated in other comprehensive income expected to reclassify from other comprehensive income into earnings, estimate of time to transfer	7 years 6 months
Cash Flow Hedges | Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	12 months
Cash Flow Hedges | Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Foreign currency cash flow hedge, expiration period	24 months

XML

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments and Restricted Cash and Investments Unrealized Loss Positions (Details) $ in Thousands	Sep. 24, 2017 USD ($)
Fair Value
Unrealized Losses Less than 12 Months	$ 2,182,398
Unrealized Losses 12 Months or Greater	4,640
Total	2,187,038
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(5,942)
Unrealized Losses 12 Months or Greater	(37)
Total	(5,979)
U.S. Treasury and agencies
Fair Value
Unrealized Losses Less than 12 Months	660,429
Unrealized Losses 12 Months or Greater	0
Total	660,429
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(2,671)
Unrealized Losses 12 Months or Greater	0
Total	(2,671)
Mutual funds
Fair Value
Unrealized Losses Less than 12 Months	3,122
Unrealized Losses 12 Months or Greater	0
Total	3,122
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(70)
Unrealized Losses 12 Months or Greater	0
Total	(70)
Municipal notes and bonds
Fair Value
Unrealized Losses Less than 12 Months	18,653
Unrealized Losses 12 Months or Greater	0
Total	18,653
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(21)
Unrealized Losses 12 Months or Greater	0
Total	(21)
Government-sponsored enterprises
Fair Value
Unrealized Losses Less than 12 Months	55,297
Unrealized Losses 12 Months or Greater	0
Total	55,297
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(322)
Unrealized Losses 12 Months or Greater	0
Total	(322)
Foreign government bonds
Fair Value
Unrealized Losses Less than 12 Months	33,729
Unrealized Losses 12 Months or Greater	0
Total	33,729
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(128)
Unrealized Losses 12 Months or Greater	0
Total	(128)
Corporate notes and bonds
Fair Value
Unrealized Losses Less than 12 Months	1,282,655
Unrealized Losses 12 Months or Greater	0
Total	1,282,655
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(2,376)
Unrealized Losses 12 Months or Greater	0
Total	(2,376)
Mortgage backed securities — residential
Fair Value
Unrealized Losses Less than 12 Months	30,210
Unrealized Losses 12 Months or Greater	2,006
Total	32,216
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(93)
Unrealized Losses 12 Months or Greater	(23)
Total	(116)
Mortgage backed securities — commercial
Fair Value
Unrealized Losses Less than 12 Months	98,303
Unrealized Losses 12 Months or Greater	2,634
Total	100,937
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(261)
Unrealized Losses 12 Months or Greater	(14)
Total	$ (275)

XML

FINANCIAL INSTRUMENTS - Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, and Restricted Cash and Investments with Contractual Maturities (Details) $ in Thousands	Sep. 24, 2017 USD ($)
Cost
Due in one year or less	$ 2,764,552
Due after one year through five years	2,987,295
Due in more than five years	143,704
Total	5,895,551
Estimated Fair Value
Due in one year or less	2,764,415
Due after one year through five years	2,986,525
Due in more than five years	143,502
Total	$ 5,894,442

XML

FINANCIAL INSTRUMENTS - Schedule of Outstanding Foreign Currency Forward Contracts (Details) - Foreign exchange forward contracts $ in Thousands	Sep. 24, 2017 USD ($)
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	$ 45,453
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	31,917
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	13,536
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	64,885
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	31,246
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	12,658
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	9,375
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	7,137
Foreign currency forward contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	4,469
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	393,345
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	393,345
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Chinese renminbi
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments
Derivative [Line Items]
Derivative notional amount	366,433
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	282,311
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Euro
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Korean won
Derivative [Line Items]
Derivative notional amount	84,122
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Taiwan dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Swiss franc
Derivative [Line Items]
Derivative notional amount	0
Foreign currency forward contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Singapore dollar
Derivative [Line Items]
Derivative notional amount	0
Foreign currency option contracts | Buy Contracts | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	36,036
Foreign currency option contracts | Buy Contracts | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	8,929
Foreign currency option contracts | Sell Contracts | Derivatives Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	0
Foreign currency option contracts | Sell Contracts | Derivatives Not Designated as Hedging Instruments | Japanese yen
Derivative [Line Items]
Derivative notional amount	$ 8,929

XML

FINANCIAL INSTRUMENTS - Schedule of Fair Value of Derivative Instruments (Details) - Fair Value of Derivative Instruments (Level 2) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	$ 10,023	$ 8,274
Liability Derivatives	13,906	13,360
Derivatives Designated as Hedging Instruments | Prepaid expense and other assets | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	9,598	8,061
Derivatives Designated as Hedging Instruments | Prepaid expense and other assets | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	316
Derivatives Designated as Hedging Instruments | Accrued expenses and other current liabilities | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	368	2,916
Derivatives Designated as Hedging Instruments | Accrued expenses and other current liabilities | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives		2,833
Derivatives Designated as Hedging Instruments | Other long-term liabilities | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	13,077	7,269
Derivatives Not Designated as Hedging Instruments | Prepaid expense and other assets | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Derivatives	109	213
Derivatives Not Designated as Hedging Instruments | Accrued expenses and other current liabilities | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liability Derivatives	$ 461	$ 342

XML

FINANCIAL INSTRUMENTS - Schedule of Derivative Instruments Designated as Cash Flow Hedges in Statements of Operations Including Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	$ 3,790	$ (2,702)
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	(2,299)	(13,432)
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	2,205	617
Foreign Exchange Contracts | Revenue
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	(9)	(2,913)
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	(3,806)	(13,605)
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	2,547	705
Foreign Exchange Contracts | Cost of goods sold
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	2,443	235
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	824	173
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	(208)	(67)
Foreign Exchange Contracts | Selling, general, and administrative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	1,356	(24)
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	714	(9)
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	(117)	(21)
Foreign Exchange Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	0	0
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	0	0
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	(17)	0
Foreign Exchange Contracts | Other income
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (Loss) Recognized In Income	2,672	(383)
Interest Rate Contracts | Other expense, net
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
(Loss) Gain Recognized in AOCI (Effective Portion)	0	0
(Loss) Gain Reclassified from AOCI into Income (Effective Portion)	(31)	9
Gain (Loss) Recognized In Income (Excluded from Effectiveness)	$ 0	$ 0

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Inventory Disclosure [Abstract]
Raw materials	$ 721,352	$ 625,600
Work-in-process	200,271	213,066
Finished goods	406,674	394,250
Total inventories	$ 1,328,297	$ 1,232,916	[1]

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016	Aug. 28, 2017	Jun. 25, 2017	[1]
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,484,030		$ 97,832	$ 1,385,673
Tax deductible goodwill	61,100
Intangible asset amortization expense	$ 39,300	$ 38,700

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,380,227	$ 1,331,427
Accumulated Amortization	(959,868)	(920,432)
Net	420,359	410,995
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	630,257	615,164
Accumulated Amortization	(383,131)	(366,439)
Net	247,126	248,725
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross	669,603	643,196
Accumulated Amortization	(508,983)	(487,056)
Net	160,620	156,140
Patents
Finite-Lived Intangible Assets [Line Items]
Gross	36,553	36,553
Accumulated Amortization	(31,872)	(31,238)
Net	4,681	5,315
Other intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross	43,814	36,514
Accumulated Amortization	(35,882)	(35,699)
Net	$ 7,932	$ 815

XML

GOODWILL AND INTANGIBLE ASSETS - Estimated Future Amortization Expense of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Fiscal Year
2018 (remaining 9 months)	$ 121,147
2019	123,429
2020	58,296
2021	55,611
2022	51,801
Thereafter	10,075
Net	$ 420,359	$ 410,995

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Jun. 25, 2017
Payables and Accruals [Abstract]
Accrued compensation	$ 510,583	$ 447,363
Warranty reserves	168,337	161,981
Income and other taxes payable	145,022	95,127
Dividend payable	73,127	72,738
Other	181,929	192,152
Accrued expenses and other current liabilities	$ 1,078,998	$ 969,361	[1]

[1] Derived from audited financial statements

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt (Details) - USD ($)	Sep. 24, 2017	Jun. 25, 2017	Jun. 07, 2016	Mar. 12, 2015	Jun. 30, 2012	May 31, 2011
Debt Instrument [Line Items]
Amount	$ 2,576,835,000	$ 2,878,510,000
Unamortized discount	(145,241,000)	(178,589,000)
Fair value adjustment - interest rate contracts	(12,761,000)	(10,102,000)
Unamortized bond issuance costs	(2,798,000)	(3,161,000)
Total debt outstanding, at carrying value	2,416,035,000	2,686,658,000
Current portion of long-term debt	639,252,000	907,827,000
Long-term debt	1,776,783,000	1,778,831,000
Total debt outstanding, at carrying value	2,416,035,000	2,686,658,000
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Senior notes interest rate						1.25%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Senior notes interest rate					2.625%
Convertible debt | Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Amount	$ 238,367,000	$ 447,436,000
Effective Interest Rate	5.27%	5.27%
Senior notes interest rate	1.25%
Convertible debt | Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Amount	$ 538,468,000	$ 631,074,000
Effective Interest Rate	4.28%	4.28%
Senior notes interest rate	2.625%
Senior notes | Fixed-rate 2.75% Senior Notes Due March 15, 2020 (2020 Notes)
Debt Instrument [Line Items]
Amount	$ 500,000,000	$ 500,000,000
Effective Interest Rate	2.88%	2.88%
Senior notes interest rate	2.75%			2.75%
Senior notes | Fixed-rate 2.80% Senior Notes Due June 15, 2021 (2021 Notes)
Debt Instrument [Line Items]
Amount	$ 800,000,000	$ 800,000,000	$ 800,000,000
Effective Interest Rate	2.95%	2.95%
Senior notes interest rate	2.80%		2.80%
Senior notes | Fixed-rate 3.80% Senior Notes Due March 15, 2025 (2025 Notes)
Debt Instrument [Line Items]
Amount	$ 500,000,000	$ 500,000,000
Effective Interest Rate	3.87%	3.87%
Senior notes interest rate	3.80%			3.80%

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Outstanding Debt Footnotes (Details) - Convertible debt	3 Months Ended
	Sep. 24, 2017 d
Debt Instrument [Line Items]
Stock price percentage of conversion price	130.00%
Number of days on which common stock sale price was greater than or equal to 130% of conversion price, in a period of 30 consecutive trading days ending on the last trading day of the preceding the quarter	20
Number of consecutive trading days period required	30 days

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Convertible Senior Notes (Details) - USD ($)	1 Months Ended	3 Months Ended
	Jun. 30, 2012	Sep. 24, 2017	May 31, 2011
Convertible debt
Debt Instrument [Line Items]
Conversion of notes		$ 301,700,000
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes)
Debt Instrument [Line Items]
Principal amount			$ 450,000,000
Senior notes interest rate			1.25%
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 (2018 Notes) | Convertible debt
Debt Instrument [Line Items]
Senior notes interest rate		1.25%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes)
Debt Instrument [Line Items]
Principal amount	$ 700,000,000
Senior notes interest rate	2.625%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes) | Convertible debt
Debt Instrument [Line Items]
Senior notes interest rate		2.625%
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 (2041 Notes) | Maximum
Debt Instrument [Line Items]
Maximum amount of contingent interest rate	0.60%

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Components of Convertible Senior Notes (Details)	3 Months Ended
	Sep. 24, 2017 USD ($) $ / shares shares	Sep. 25, 2016	Jun. 25, 2017 USD ($)
2018 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	6 months 23 days	9 months 23 days
Fair Value of Notes (Level 2)	$ 697,829,000
Conversion rate (shares of common stock per $1,000 principal amount of notes)	0.0166142
Principal amount of convertible debt conversion increments	$ 1,000
Conversion price (per share of common stock) (in dollars per share) | $ / shares	$ 60.19
If-converted value in excess of par value	$ 461,533,000
Estimated share dilution using average quarterly stock price $159.71 per share | shares	2,468,000
Average quarterly stock price (in dollars per share) | $ / shares	$ 159.71
Shares received during settlement | shares	2,092,000
2018 Notes | Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 92,388,000		$ 89,604,000
2018 Notes | Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 5,816,000		15,186,000
2041 Notes
Debt Instrument [Line Items]
Remaining amortization period (years)	23 years 6 months 23 days	23 years 9 months 23 days
Fair Value of Notes (Level 2)	$ 2,805,294,000
Conversion rate (shares of common stock per $1,000 principal amount of notes)	0.0298160
Principal amount of convertible debt conversion increments	$ 1,000
Conversion price (per share of common stock) (in dollars per share) | $ / shares	$ 33.54
If-converted value in excess of par value	$ 2,298,926,000
Estimated share dilution using average quarterly stock price $159.71 per share | shares	12,683,000
Average quarterly stock price (in dollars per share) | $ / shares	$ 159.71
2041 Notes | Permanent Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 157,210,000		156,374,000
2041 Notes | Temporary Equity
Debt Instrument [Line Items]
Carrying amount of equity component, net of tax	$ 131,180,000		$ 154,675,000

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Warrants and Convertible Note Hedge Arrangements (Details) - $ / shares shares in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Class of Warrant or Right [Line Items]
Estimated share dilution using average quarterly stock price $159.71 per share	4,074	2,048
2018 Notes
Class of Warrant or Right [Line Items]
Average quarterly stock price (in dollars per share)	$ 159.71
2018 Notes | Warrants
Class of Warrant or Right [Line Items]
Underlying shares	7,476
Estimated share dilution using average quarterly stock price $159.71 per share	4,074
Average quarterly stock price (in dollars per share)	$ 159.71
Exercise price (in dollars per share)	72.69
2018 Notes | Convertible Note Hedge
Class of Warrant or Right [Line Items]
Exercise price (in dollars per share)	$ 60.19
Number of shares available from counterparties	3,960

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Senior Notes (Details) - USD ($)		3 Months Ended
	Mar. 12, 2015	Sep. 24, 2017	Jun. 25, 2017	Jun. 07, 2016
Debt Instrument [Line Items]
Amount		$ 2,576,835,000	$ 2,878,510,000
Senior notes
Debt Instrument [Line Items]
Percentage of principal amount of debt redeemed	100.00%
Senior notes | 2020 Notes
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate	2.75%	2.75%
Amount		$ 500,000,000	500,000,000
Senior notes | 2025 Notes
Debt Instrument [Line Items]
Principal amount	$ 500,000,000
Senior notes interest rate	3.80%	3.80%
Debt instrument, redemption price (percentage)	101.00%
Amount		$ 500,000,000	500,000,000
Senior notes | 2021 Notes
Debt Instrument [Line Items]
Senior notes interest rate		2.80%		2.80%
Percentage of principal amount of debt redeemed		100.00%
Debt instrument, redemption price (percentage)		101.00%
Amount		$ 800,000,000	$ 800,000,000	$ 800,000,000

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Additional Senior Notes Information (Details) $ in Thousands	3 Months Ended
	Sep. 24, 2017 USD ($)
2020 Notes
Debt Instrument [Line Items]
Remaining Amortization Period (years)	2 years 5 months 18 days
2021 Notes
Debt Instrument [Line Items]
Remaining Amortization Period (years)	3 years 8 months 20 days
2025 Notes
Debt Instrument [Line Items]
Remaining Amortization Period (years)	7 years 5 months 18 days
Fair Value of Derivative Instruments (Level 2) | 2020 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 507,915
Fair Value of Derivative Instruments (Level 2) | 2021 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	810,384
Fair Value of Derivative Instruments (Level 2) | 2025 Notes
Debt Instrument [Line Items]
Fair Value of Notes (Level 2)	$ 518,625

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Schedule of Recognized Interest Cost Relating to Both Contractual Interest Coupon and Amortization of Discount on Liability Component of Notes (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Debt Disclosure [Abstract]
Contractual interest coupon	$ 17,956	$ 34,712
Amortization of interest discount	4,104	5,914
Amortization of issuance costs	485	918
Effect of interest rate contracts, net	(349)	(1,058)
Total interest cost recognized	$ 22,196	$ 40,486

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Revolving Credit Facility (Details) - Revolving credit facility - USD ($)	Apr. 26, 2016	Oct. 13, 2017	Mar. 05, 2015
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility	$ 750,000,000		$ 300,000,000
Additional increase in the facility	250,000,000
Revolving unsecured credit facility maximum borrowing capacity	$ 1,000,000,000
Scenario, forecast
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility		$ 1,850,000,000
Additional increase in the facility		600,000,000
Subsequent event
Extinguishment of Debt [Line Items]
Revolving unsecured credit facility		1,250,000,000
Additional increase in the facility		$ 500,000,000
Federal Funds Rate
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
One-month LIBOR
Extinguishment of Debt [Line Items]
Variable interest spread	1.00%
One-month LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.00%
One-month LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	0.50%
LIBOR | Minimum
Extinguishment of Debt [Line Items]
Variable interest spread	0.90%
LIBOR | Maximum
Extinguishment of Debt [Line Items]
Variable interest spread	1.50%

XML

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 24, 2017	Jun. 25, 2017	[1]
Loss Contingencies [Line Items]
Restricted cash and investments	$ 256,045,000	$ 256,205,000
Letters of Credit
Loss Contingencies [Line Items]
Guarantee obligation maximum exposure	20,600,000
Operating Leases
Loss Contingencies [Line Items]
Operating lease residual value of guarantee, maximum	$ 220,400,000
Maximum percentage of aggregate investment value guaranteed	100.00%
Guarantee obligation maximum exposure	$ 250,000,000.0
Operating Lease Cash Collateral
Loss Contingencies [Line Items]
Restricted cash and investments	$ 250,000,000

[1] Derived from audited financial statements

XML

COMMITMENTS AND CONTINGENCIES - Schedule of Changes in Product Warranty Reserves (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Changes in Product Warranty Reserve
Balance at beginning of period	$ 161,981	$ 100,321
Warranties issued during the period	48,790	34,855
Settlements made during the period	(44,053)	(32,228)
Changes in liability for pre-existing warranties	1,619	278
Balance at end of period	$ 168,337	$ 103,226

XML

STOCK REPURCHASE PROGRAM - Additional Information (Details) $ / shares in Units, shares in Thousands			3 Months Ended
	Jun. 30, 2017 $ / shares shares	Apr. 19, 2017 USD ($) financial_institution agreement shares	Sep. 24, 2017 USD ($) shares	Nov. 30, 2016 USD ($)
Equity [Abstract]
Authorized repurchase of Company common stock (up to)				$ 1,000,000,000
Net shares of settlements to cover tax withholding obligations (in shares) | shares			11
Amount paid for shares under net share settlements			$ 1,800,000
Number of accelerated share repurchase agreements | agreement		2
Number of financial institutions | financial_institution		2
Total repurchase amount		$ 500,000,000
Number of shares repurchased | shares	780	2,570	1,779
Percent of prepayment divided by closing stock price		70.00%
Weighted-average share price | $ / shares	$ 149.16

XML

STOCK REPURCHASE PROGRAM - Repurchases Under the Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands			3 Months Ended
	Jun. 30, 2017	Apr. 19, 2017	Sep. 24, 2017	Jun. 25, 2017
Equity [Abstract]
Total Number of Shares Repurchased	780	2,570	1,779
Total Cost of Repurchase			$ 157,938
Average Price Paid Per Share (in dollars per share)			$ 158.40
Amount Available Under Repurchase Program (shares)			$ 124,203	$ 282,141

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands		3 Months Ended
		Sep. 24, 2017	Sep. 25, 2016
Change in Accumulated Other Comprehensive Loss
Beginning balance	[1]	$ 6,817,451
Other comprehensive income (loss) before reclassifications		6,865
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income		2,048
Other comprehensive income, net of tax		8,913	$ 12,333
Ending balance		7,271,178
Accumulated Foreign Currency Translation Adjustment
Change in Accumulated Other Comprehensive Loss
Beginning balance		(42,371)
Other comprehensive income (loss) before reclassifications		7,886
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income		(17)
Other comprehensive income, net of tax		7,869
Ending balance		(34,502)
Accumulated Unrealized Holding Gain (Loss) on Cash flow hedges
Change in Accumulated Other Comprehensive Loss
Beginning balance		(811)
Other comprehensive income (loss) before reclassifications		3,062
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income		2,188
Other comprehensive income, net of tax		5,250
Ending balance		4,439
Accumulated Unrealized Holding Gain (Loss) on Available-For-Sale Investments
Change in Accumulated Other Comprehensive Loss
Beginning balance		1,106
Other comprehensive income (loss) before reclassifications		(1,727)
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income		(123)
Other comprehensive income, net of tax		(1,850)
Ending balance		(744)
Accumulated Unrealized Components of Defined Benefit Plans
Change in Accumulated Other Comprehensive Loss
Beginning balance		(19,624)
Other comprehensive income (loss) before reclassifications		(2,356)
Losses (income) reclassified from accumulated other comprehensive income (loss) to net income		0
Other comprehensive income, net of tax		(2,356)
Ending balance		(21,980)
Total
Change in Accumulated Other Comprehensive Loss
Beginning balance		(61,700)
Ending balance		$ (52,787)

[1] Derived from audited financial statements

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Foot Notes) (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 24, 2017	Sep. 25, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	$ 2,478,140	$ 1,632,419
Cost of goods sold	1,328,797	916,222
Selling, general, and administrative	181,043	165,010
Other income and expense	(5,502)	$ (23,154)
Accumulated Unrealized Holding Gain (Loss) on Cash flow hedges | Reclassified from accumulated other comprehensive income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	(3,383)
Cost of goods sold	678
Selling, general, and administrative	537
Other income and expense	$ (20)

XML

BUSINESS COMBINATIONS - Additional Information (Details) $ in Millions	Aug. 28, 2017 USD ($)
Business Combinations [Abstract]
Total purchase consideration	$ 137.6

XML

BUSINESS COMBINATIONS - Schedule of Preliminary Purchase Price Allocation (Details) - USD ($) $ in Thousands	Sep. 24, 2017	Aug. 28, 2017	Jun. 25, 2017	[1]
Business Combinations [Abstract]
Intangible assets		$ 48,500
Assets acquired		12,796
Goodwill	$ 1,484,030	97,832	$ 1,385,673
Liabilities assumed		(21,517)
Fair value of net assets acquired		137,611
Cash acquired		$ 8,700

[1] Derived from audited financial statements

XML

BUSINESS COMBINATIONS - Schedule of Identified Intangible Assets Assumed in the Acquisition (Details) $ in Thousands	Aug. 28, 2017 USD ($)
Fair Value
Finite-lived intangible assets	$ 48,500
Weighted-Average Estimated Useful Life	6 years
Existing technology
Fair Value
Finite-lived intangible assets	$ 26,200
Weighted-Average Estimated Useful Life	6 years
Customer relationships
Fair Value
Finite-lived intangible assets	$ 15,000
Weighted-Average Estimated Useful Life	6 years
Trade names and other intangible assets
Fair Value
Finite-lived intangible assets	$ 7,300
Weighted-Average Estimated Useful Life	6 years 4 months 25 days